ethambutol has been researched along with Tuberculosis, Drug-Resistant in 286 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.35) | 18.7374 |
1990's | 40 (13.99) | 18.2507 |
2000's | 64 (22.38) | 29.6817 |
2010's | 142 (49.65) | 24.3611 |
2020's | 39 (13.64) | 2.80 |
Authors | Studies |
---|---|
Akhalaia, M; Gegia, M; Han, J; Khechinashvili, G; Li, H; Mdivani, N; Mendes, RE; Tang, YW | 1 |
Alves, M; Del Olmo, E; Escarcena, R; Feliciano, AS; Hernandez-Pando, R; López-Pérez, JL; Molina-Salinas, GM; Said-Fernández, S | 1 |
Hongmanee, P; Kittakoop, P; Mahidol, C; Ruchirawat, S; Senadeera, SP; Sureram, S | 1 |
Moreno-Viguri, E; Pérez-Silanes, S; Santivañez-Veliz, M; Torres, E | 1 |
Feng, LS; Gao, C; Hu, YQ; Lv, ZS; Wu, X; Xu, Z; Zhang, S; Zhao, F | 1 |
Dogonadze, M; Kraeva, L; Krasavin, M; Lukin, A; Manicheva, O; Rogacheva, E; Vedekhina, T; Vinogradova, T; Yablonsky, P; Zabolotnykh, N | 1 |
Chopra, S; Dusthackeer, VNA; Krishna, EV; Krishna, VS; Mahizhaveni, B; Makane, VB; Misra, S; Rode, HB; Shukla, M; Sriram, D | 1 |
Chen, M; Jiang, W; Jiang, X; Li, D; Li, Y; Lin, Y; Liu, C; Si, S; Xu, Y; You, X; Zhang, J | 1 |
Chopra, S; Dasgupta, A; Kaul, G; Kumar Sahoo, S; Maddipatla, S; Madhavi Yaddanapudi, V; Nageswara Rao Gajula, S; Naiyaz Ahmad, M; Nanduri, S; Sonti, R | 1 |
Alves, S; Amorim, RVS; Azevedo, LA; Linhares, LA; Montenegro, LML; Oliveira, MEFAG; Silva, YJA | 1 |
Ahmed, S; Banu, S; Khatun, R; Nasrin, R; Rahman, A; Rahman, MM; Rahman, SMM; Uddin, MKM | 1 |
Kumar, MS; Raghavan, V; Sundari, S; Vigneshwaran, J | 1 |
Bwalya, P; Chizimu, JY; Mbulo, G; Nakajima, C; Shrestha, D; Solo, ES; Suzuki, Y; Thapa, J | 1 |
Guo, Y; Liu, H; Sha, W; Shen, H; Shen, X; Tan, G; Wu, X; Wu, Z; Yang, J; Yu, F | 1 |
Jiang, H; Li, X; Niu, Q; Xing, Z; Xu, J | 1 |
He, G; Jiang, X; Ning, H; Qiu, C; Shi, J; Wu, L; Wu, Z; Ye, X | 1 |
Al-Rabeai, DB; Khudhair, GS; Mohammed, KAS | 1 |
Addise, D; Beyene, D; Merker, M; Mesfin, EA; Niemann, S; Shuaib, YA; Tesfaye, A; Tessema, B | 1 |
Kang, JY; Kim, HW; Kim, JS; Kim, JW; Kim, SK; Kim, YH; Lee, SH; Min, J; Yoon, HK | 1 |
Alarcón, MJ; Coronel, J; Cotrina, VV; Moore, DAJ; Puyén, ZM; Santos-Lázaro, D; Vigo, AN | 1 |
Che, Y; Chen, Q; Chen, T; He, T; Lin, Y; Sang, G; Yang, T | 1 |
Doulla, B; Ershova, J; Heinrich, N; Hoelscher, M; Kilale, AM; Kingalu, A; Kisonga, R; Kondo, Z; Lema, Y; Lyamuya, E; Lyimo, J; Mfaume, SM; Mutayoba, BK; Ngowi, BJ; Nkiligi, E; Ntinginya, NE; Pletschette, M; Range, NS | 1 |
Ahmed, S; Biswas, JP; Das, BR; Haque, N; Hasan, M; Hasan, MS; Hossain, MA; Islam, A; Khan, MK; Nasreen, SA; Paul, SK | 1 |
Dookie, N; Naicker, N; Naidoo, K; Ngema, SL; Padayatchi, N; Perumal, R | 1 |
Hsiao, HC; Jou, R; Wu, SH; Xiao, YX | 1 |
Al Moujahid, A; Bletsis, PP; de Jong, T; van den Elskamp, IJ; Wink, FR | 1 |
Brandao, AP; Ferrazoli, L; Gallo, JF; Oliveira, RS; Pinhata, JMW | 1 |
Avihingsanon, A; Balanag, VM; Burhan, E; Chew, KL; Cousins, C; Crook, AM; Dalay, VB; Djaharuddin, I; Kusmiati, T; Lee, SL; Lu, Q; Nunn, AJ; Papineni, P; Paton, NI; Pokharkar, Y; Ruslami, R; Sarin, R; Sekaggya-Wiltshire, C; Sugiri, JJR; Suresh, C; Veto, RS | 1 |
Chaiprasert, A; Chaiyachat, P; Faksri, K; Kaewseekhao, B; Kamolwat, P; Nonghanphithak, D; Ong, RT; Phetcharaburanin, J; Sirichoat, A | 1 |
Alves Pereira, VR; Carneiro Neves, MM; Correia de Sousa, LA; da Silva Santos, AC; de la Vega, J; Dos Santos Peixoto, A; Ferreira, LFGR; Hernandes, MZ; Linhares, LA; Lucena Laet, JP; Montenegro, LML; Olmo, ED; Pereira-Neves, A; San Feliciano, A; Schindler, HC | 1 |
Berge, I; Bogdanova, I; Freimane, L; Norvaiša, I; Ozere, I; Ranka, R; Sadovska, D; Vaivode, A; Vīksna, A | 1 |
Chaturvedi, V; Trivedi, P | 1 |
Altın, S; Hırçın Cenger, D; Kılıç, L; Yazısız, H; Yazısız, V | 1 |
Hussain, W; Khadim, MT; Khurshid, U; Salim, S; Younis, S; Zaman, G | 1 |
Heyckendorf, J; Kalsdorf, B; Lange, C; Maurer, FP | 1 |
Altin, S; Hircin Cenger, D; Uçarman, N; Yazisiz, H | 1 |
Ader, F; Berland, JL; Bryant, JE; Dumitrescu, O; Genestet, C; Ginevra, C; Hodille, E; Lina, G | 1 |
Huynh, J; Marais, BJ; Schaaf, HS; Thwaites, G | 1 |
Amanullah, F; Becerra, MC; Cranmer, LM; Fuad, J; Gandhi, NR; Hussain, H; Jaswal, M; Keshavjee, S; Lash, TL; Malik, AA; Omer, SB; Salahuddin, N; Siddiqui, S | 1 |
Desai, U; Doshi, K; Joshi, JM | 1 |
Jafari, R; Moghim, S; Nasr Esfahani, B; Safari, M; Salehi, M | 1 |
Aung, KJM; de Jong, BC; Decroo, T; Hossain, MA; Lempens, P; Meehan, CJ; Rigouts, L; Van Deun, A | 1 |
Basol, G; Gonlugur, T; Gonlugur, U | 1 |
Eather, G; Matigian, N; O'Connor, B; Wilson, M | 1 |
Becker, P; Keddy, KH; Lancaster, J; Shean, K; van der Walt, ML | 1 |
Deng, W; Gong, Z; Sun, Q; Xiang, X; Xie, J | 1 |
Chaiprasert, A; Chaiyachat, P; Faksri, K; Kaewprasert, O; Nonghanphithak, D; Reechaipichitkul, W | 1 |
Ahmad, N; Atif, M; Ghafoor, A; Iqbal, Q; Khan, S; Latif, A; Saleem, F; Wahid, A | 1 |
Ahmad, S; Al-Mutairi, NM; Mokaddas, E | 2 |
Marks, SM; Mase, SR; Morris, SB | 1 |
Ahn, Y; Eun, BW; Kim, HJ; Ryoo, S; Yoon, HH | 1 |
Chirehwa, MT; Denti, P; McIlleron, H; Mthiyane, T; Onyebujoh, P; Rustomjee, R; Smith, P | 1 |
Khan, MI; Mahmood, N; Munir, S; Shahid, S | 1 |
Anupurba, S; Balgam, S; Fakir, NA; Gupta, A; Nema, V; Pal, SK; Pandey, D; Periera, M; Rathod, S; Sekar, G; Sinha, D; Sinha, P; SivaKumar, S; UmaDevi, KR | 1 |
Jo, KW; Kim, WS; Lee, SD; Park, S; Shim, TS | 1 |
He, XC; Li, HC; Liu, Y; Tao, NN; Yu, CB; Zhang, XX | 1 |
Bhatta, RS; Chauhan, S; Chopra, S; Dasgupta, A; Gupta, P; Gupta, UD; Karaulia, P; Puttrevu, SK; Singh, AK; Singh, VK; Tadigoppula, N; Yadav, P | 1 |
Chen, J; Chiang, CY; Innes, AL; Li, L; Xu, L | 1 |
Anukool, U; Butr-Indr, B; Gamngoen, R; Intorasoot, S; Jaresitthikunchai, J; Kasinrerk, W; Phaonakrop, N; Phunpae, P; Putim, C; Roytrakul, S; Tayapiwatana, C; Tharincharoen, CS; Tragoolpua, K | 1 |
de Kock, M; Denti, P; Garcia-Prats, AJ; Hesseling, AC; McIlleron, H; Norman, J; Schaaf, HS; Tikiso, T; van der Laan, LE; Wiesner, L; Winckler, J | 1 |
Huh, HJ; Jeon, K; Jeong, BH; Kim, S; Lee, H; Lee, NY; Park, HY | 1 |
Clifton, DA; Crook, DW; Iqbal, Z; Niehaus, KE; Peto, TEA; Smith, EG; Walker, AS; Walker, TM; Wilson, DJ; Yang, Y; Zhu, T | 1 |
Ahmed, AE; Al Ammari, M; Al Essa, M; Al Turaiki, A; Eltigani, SA; Kashkary, AM | 1 |
Abebe, M; Ameni, G; Aseffa, A; Desta, K; Tilahun, M; Yamuah, L; Zewude, A | 1 |
Agiboth, HKK; Angamuthu, P; Arasan, G; Ayyamperumal, M; Chandrasekaran, P; Chockalingam, C; Gopalan, N; Jayabal, L; Jayanthi, N; Kannabiran, BP; Kesavamurthy, B; Krishnamoorthy, V; Krishnaraja, R; Lakshman, S; Manoharan, T; Menon, PA; Murali, L; Narayanan, R; Palaniappan, AN; Ramachandran, R; Rathinam, P; Rathinam, S; Reddy, D; Santhanakrishnan, RK; Satagopan, K; Sathiyavelu, S; Selvachitiram, M; Sivaramakrishnan, GN; Suresh, C; Susaimuthu, S; Swaminathan, S; Tripathy, SP | 1 |
Ahuja, SD; Akkerman, OW; Arakaki-Sanchez, D; Ayakaka, I; Baghaei, P; Bang, D; Banurekha, VV; Bastos, M; Benedetti, A; Bonnet, M; Cattamanchi, A; Cegielski, P; Chien, JY; Cox, H; Dedicoat, M; Erkens, C; Escalante, P; Falzon, D; Fregonese, F; Galliez, RM; Garcia-Prats, AJ; Gegia, M; Gillespie, SH; Glynn, JR; Goldberg, S; Griffith, D; Jacobson, KR; Johnston, JC; Jones-López, EC; Khan, A; Koh, WJ; Kritski, A; Lan, ZY; Lee, JH; Li, PZ; Maciel, EL; Menzies, D; Merle, CSC; Munang, M; Narendran, G; Nguyen, VN; Nunn, A; Ohkado, A; Park, JS; Phillips, PPJ; Ponnuraja, C; Reves, R; Romanowski, K; Schaaf, HS; Seung, K; Skrahina, A; Soolingen, DV; Tabarsi, P; Trajman, A; Trieu, L; Viiklepp, P; Wang, JY; Yoshiyama, T | 1 |
Li, Q; Liu, W; Lu, M; Qian, HZ; Wang, K; Wang, L; Wu, L; Wu, Y; Xie, L; Zhao, G | 1 |
Bollela, VR; Dippenaar, A; Feliciano, CS; Namburete, EI; Peronni, K; Rodrigues Plaça, J; Silva, WA; Warren, RM | 1 |
Addise, D; Admasu, A; Amare, M; Beyene, D; Dagne, B; Mesfin, EA; Tesfaye, A; Tesfaye, E; Tessema, B; Yaregal, Z | 1 |
Ali, S; Dominguez, J; Féres Saad, MH; Gomes, HM; Gomgnimbou, MK; Klotoe, BJ; Molina-Moya, B; Oliveira Suzarte, L; Pimkina, E; Refrégier, G; Sola, C; Zholdybayeva, E | 1 |
Ahmad, M; Ahmad, W; Akbar, HS; Akbar, MT; Jan, F; Khalid, A; Sadia, S; Wali, S | 1 |
Abrahem, R; Cao, R; Gyurjian, K; Islamoglu, H; Munjal, S; Teskey, G; Venketaraman, V; Zhong, L | 1 |
Boulle, A; Fox, T; Khomo, N; Kock, Y; Leslie, J; Manning, K; Meintjes, G; Mudaly, V; Stewart, A; Tiffin, N; Wasserman, S; Zhao, Y | 1 |
Cao, P; Doan, TN; Emeto, TI; McBryde, ES; McCaw, JM | 1 |
Huang, H; Jiao, W; Li, J; Li, Q; Liu, S; Mokrousov, I; Qi, H; Shen, A; Shen, C; Sun, L; Wang, T; Xiao, J; Xu, F; Yin, Q; Zhang, L | 1 |
Ahn, H; Cho, YJ; Choi, HS; Choi, SM; Hahn, S; Han, J; Heo, EY; Hwang, YR; Jeong, I; Jo, YS; Joh, JS; Ki, J; Kim, DK; Kim, H; Kim, HS; Kim, J; Kim, SJ; Kwak, N; Lee, CH; Lee, J; Lee, JH; Lee, JK; Lee, JY; Lee, M; Lee, SH; Lee, SM; Lee, YJ; Lim, JN; Park, JH; Park, JS; Park, SS; Park, YS; Song, T; Yim, JJ; Yoon, HI | 1 |
Alarcón Guizado, VA; Alarcon, E; Cornejo Garcia, JG; Heldal, E; Mendoza Ticona, A; Moore, DAJ | 1 |
Bang, H; Delva, S; Joissaint, G; Koenig, SP; Pape, JW; Peeples, M; Pry, J; Royal, G; Souroutzidis, A; Vilbrun, SC; Walsh, KF; Widmann, P | 1 |
Ahmad, S; Al-Mutairi, NM; Eldeen, HS; Joseph, S; Mokaddas, E | 1 |
Allahyar Torkaman, MR; Amini, S; Hamzehloo, G; Hoffner, S; Mir, R; Mohsenpoor, M; Nasiri, MJ; Salehi, M; Sami Kashkooli, G; Shahraki, MS; Soleimanpour, S | 1 |
Aragón Fernández, C; Gomez-Pastrana, D; Morales Pérez, C; Pérez Escolano, E | 1 |
Chaiprasert, A; Chongtrakool, P; Ngamskulrungroj, P; Suwannakarn, K; Tulyaprawat, O | 2 |
Avihingsanon, A; Ballif, M; Blöchliger, N; Borrell, S; Böttger, EC; Collantes Loo, J; Egger, M; Gagneux, S; Gnokoro, J; Gygli, SM; Hömke, R; Keller, PM; Loiseau, C; Reinhard, M; Ritter, C; Sander, P; Yotebieng, M | 1 |
Nair, SG; Patel, DB; Patel, HD; Rathwa, SK; Vasava, MS | 1 |
Altmann, D; Brodhun, B; Glasauer, S; Haas, W; Hauer, B; Perumal, N | 1 |
Akkerman, OW; Alffenaar, JC; Hak, E; Pradipta, IS; Van't Boveneind-Vrubleuskaya, N | 1 |
Abbara, A; Abubakar, I; Alexander, E; Booth, H; Bothamley, GH; Creer, DD; Davidson, JA; Harris, RJ; Kon, OM; Kunst, H; Lalor, MK; Lipman, MC; Loebinger, MR; Loutet, MG; Lozewicz, S; McHugh, TD; Milburn, HJ; Mohiyuddin, T; Palchaudhuri, P; Phillips, PPJ; Schmok, E; Stagg, HR; Taylor, L | 1 |
Abuljadayel, N; Al-Hajoj, S; Al-Herbwai, M; Al-Omari, R; Al-Thawadi, S; Alrabiah, F; Alrajhi, AA; Memish, Z; Raviglione, MC; Shoukri, MM; Varghese, B; Zignol, M; Zumla, A | 1 |
Hishiki, H; Ichimoto, K; Ishiwada, N; Kinoshita, K; Kohno, Y; Nagasawa, K; Tokunaga, O | 1 |
Choe, KH; Chung, GT; Hwang, SC; Jnawali, HN; Kim, H; Lee, YS; Park, YK; Ryoo, S | 1 |
Buu, TN; Cobelens, FG; Dung, NH; Huyen, MN; Kremer, K; Lan, NT; Tiemersma, EW; van Soolingen, D | 1 |
Bremang, S; Casey, R; Connell, D; Evans, JT; Hawkey, PM; Hingley-Wilson, SM; Jepson, A; Kon, OM; Lalvani, A; Philip, S; Smith, GE | 1 |
Benedetti, A; Law, S; Menzies, D; Oxlade, O; Schwartzman, K | 1 |
Cox, H; Fielding, K; Finlayson, H; Godfrey-Faussett, P; Hesseling, AC; Hughes, J; Schaaf, HS; Seddon, JA | 1 |
Caleffi-Ferracioli, KR; Cardoso, RF; Maltempe, FG; Siqueira, VL | 1 |
Ahui, BJ; Aka-Danguy, E; Anon, JC; Bakayoko, AS; Brou-Gode, VC; Horo, K; Itchy, MV; Koffi, MO; Kouassi, AB; N'Gom, AS; N'Goran, NB | 1 |
Ando, H; Hang, NT; Hung, NV; Keicho, N; Kuwahara, T; Lien, LT; Sakurada, S; Thuong, PH; Thuy, TT | 1 |
Berhan, A; Berhan, Y; Yizengaw, D | 1 |
Augustynowicz-Kopeć, E; Bakuła, Z; Bielecki, J; Jagielski, T; Napiórkowska, A; Zwolska, Z | 1 |
Behera, C; Krishna, K; Singh, HR | 1 |
Kam, KM; Pang, Y; Wang, Y; Zhang, Z | 1 |
Blyth, CC; Colby, S; Fagan, JM; Francis, JR; Waring, J | 1 |
Bhattacharya, S; Choudhury, S; Das, A; Das, SK; Pandit, S | 1 |
Kedarisetty, CK; Khillan, V; Kumar, N; Kumar, S; Sarin, SK | 1 |
Anthony, RM; den Hertog, AL; Hoffner, S; Menting, S; Smienk, ET; Werngren, J | 1 |
Liu, B; Pang, Y; Wang, Y; Zhang, D | 1 |
Chiang, CY; Madan, J; Meredith, SK; Nunn, AJ; Phillips, PP; Rusen, ID; Squire, SB; Torrea, G; Van Deun, A | 1 |
Boukary, I; Daouda, M; Hanki, Y; Harouna, SH; Morou, S; Piubello, A; Souleymane, MB; Van Deun, A | 1 |
Anyo, G; Burgos, M; Cook, SV; Enarson, DA; Jindani, A; Kim, SJ; Lienhardt, C; Nunn, AJ; Rigouts, L; Yorke-Edwards, V | 1 |
Fushimi, K; Matsui, H; Yamana, H; Yasunaga, H | 1 |
Jiang, Y; Li, GL; Liu, HC; Sun, Q; Wan, KL; Wu, XC; Xiao, TY; Zeng, CY; Zhao, LL; Zhao, XQ | 1 |
Cai, X; Ding, X; Li, Y; Tan, S; Tan, Y | 1 |
Bharti, H; Bhushan, B; Chander, R; Gupta, A; Kajal, NC; Ranga, V | 1 |
Burger, DA; Conradie, A; Dawson, R; Diacon, AH; Donald, PR; Eisenach, K; Everitt, D; Ive, P; Mendel, CM; Ntinginya, NE; Page-Shipp, L; Pym, A; Reither, K; Schall, R; Spigelman, M; van Niekerk, C; Variava, E; Venter, A; von Groote-Bidlingmaier, F | 1 |
Abena Foe, JL; Aït-Khaled, N; Kuaban, C; Noeske, J; Rieder, HL; Trébucq, A | 1 |
Chakraborty, S; Rhee, KY | 1 |
Cobelens, FG; Gomez, GB; Joloba, M; Kasule, GW; Lukoye, D; Musisi, K; Ssengooba, W | 1 |
Ji, Z; Li, L; Xu, K; Yan, J; Zhang, Z | 1 |
Ayati Fard, SF; Bahrami Taghanaki, HR; Ghazvini, K; Salehi, M; Shakiba, A; Tavanaee Sani, A | 1 |
Arce-Mendoza, AY; Quintanilla-Siller, A; Rendon, A; Rodríguez-Castillo, JA; Rosas-Taraco, AG; Salinas-Carmona, MC | 1 |
Abebe, M; Adane, K; Ameni, G; Aseffa, A; Bekele, S | 1 |
Almaraz-Velasco, R; Cuevas-Córdoba, B; Juárez-Eusebio, DM; Laniado-Laborin, R; Muñiz-Salazar, R; Zenteno-Cuevas, R | 1 |
Izzatun, N; K, S; Lisdawati, V; M, M; Parwati, I; Puspandari, N; Ratnasari, L; Rif'ati, L; Soekarno, T | 1 |
Bañuls, AL; Dang, DA; Duong, CM; Nguyen, HQ; Nguyen, HV; Nguyen, NA; Nguyen, VA; Tran, TH; Vu, TT | 1 |
Albuquerque, J; David, S; Duarte, EL; Gonçalves, G; Lavinha, J; Mateus, AR; Portugal, C; Sancho, L | 1 |
Huang, H; Ke, Z; Liu, S; Mao, X; Shi, X; Tang, B; Wang, J | 1 |
Du, J; Fu, Y; Gao, J; Hu, D; Li, L; Li, Q; Li, X; Liu, F; Ma, L; Ma, Y; Tan, S; Zhang, L; Zhang, Y; Zhu, G | 1 |
Guo, Q; Liu, R; Pan, Y; Peng, Z; Xing, L; Yang, Z; Zhu, C | 1 |
He, XC; Li, HC; Liu, Y; Yang, GR; Yu, CB; Zhang, XX; Zhao, JN | 1 |
Akbal, AU; Birinci, A; Cayci, YT; Coban, AY; Durupinar, B; Uzun, M | 1 |
Demissie, M; Hamusse, SD; Hussen, MS; Lindtjørn, B; Teshome, D | 1 |
Hosmane, GB; Jain, A; Kushwaha, RA; Prasad, R; Singh, A; Srivastava, R | 1 |
Chen, SS; Guan, CX; Liu, HC; Liu, M; Liu, ZG; Song, Y; Wan, KL; Wan, L; Wu, YM; Xu, YJ; Zhao, XQ | 1 |
Betsuyaku, T; Goto, H; Hasegawa, N; Hayashi, Y; Hoshino, Y; Ishii, M; Izumi, K; Kurashima, A; Matsuda, S; Morimoto, K; Morino, E; Nakagawa, T; Namkoong, H; Nishimura, T; Ogawa, K; Sasaki, Y; Shiraishi, Y; Takasaki, J; Yoshiyama, T | 1 |
Bollela, VR; Ferro, JJ; Harrison, LH; Lisboa, M; Namburete, EI; Passeri, M; Pocente, R; Tivane, I | 1 |
Becerra, MC; Calderon, RI; Contreras, CC; Galea, JT; Huang, CC; Lecca, LW; Mitnick, CD; Murray, MB; Velásquez, GE; Yataco, RM; Zhang, Z | 1 |
Blackmore, T; McNaughton, A; McNaughton, H | 1 |
Amukoye, E; Kariuki, S; Kerubo, G; Niemann, S | 1 |
Dookie, N; Moodley, P; Sturm, AW | 1 |
Centis, R; D'Ambrosio, L; Fuentes, Z; Migliori, GB; Sotgiu, G; Tiberi, S; Zumla, A | 1 |
Aung, HL; Cook, GM; Crump, JA; Latt, KZ; Nyunt, WW; Samaranayaka, A; Thinn, KK; Tun, T | 1 |
Ahmad, N; Javaid, A; Khan, AH; Shaheen, Z | 1 |
Baya, B; Belson, M; Coulibaly, N; Coulibaly, YI; Dao, S; Dembele, BPP; Diabate, S; Diallo, MH; Diallo, S; Diarra, B; Goita, D; Kone, A; Kone, B; M'Baye, O; Maiga, M; Murphy, RL; Orsega, S; Polis, MA; Saleeb, P; Sanogo, M; Sarro, YS; Siddiqui, S; Somboro, AM; Togo, ACG; Traore, B | 1 |
Mebrahtu, T; Weldegebreal, S | 1 |
Mendel, C; Murray, S; Spigelman, M | 1 |
Ani, AE; Dalyop, YB; Idoko, J; Pitmang, SL | 1 |
Coelho, E; De Capitani, EM; Joaquim, OA; Nunes, EA; Panunto, AC; Ramos, Mde C | 1 |
Borgdorff, MW; He, GX; Jiang, GL; Liu, YH; van den Hof, S; van der Werf, MJ; Wang, LX; Wang, SF; Xia, H; Zhao, YL | 1 |
Kononets, AS | 1 |
Ershova, NG; Gubkina, MF | 1 |
Arslan, Z; Babacan, F; Cimen, NO; Kurutepe, M; Ocak, K; Saygi, A | 1 |
Bergmann, JF; Delcey, V; Raskine, L; Sanson-Le-Pors, MJ; Sellier, P | 1 |
Chiang, CY; Jou, R; Wu, MH; Yu, CY | 1 |
Cox, HS; Doshetov, D; Kalon, S; Niemann, S; Plinke, C; Rüsch-Gerdes, S | 1 |
Chauhan, DS; Gupta, AK; Katoch, VM; Sharma, R; Sharma, VD; Singh, M; Venkatesan, K | 1 |
Gumbo, T | 1 |
Bessong, PO; de Villiers, BE; Green, E; Hoosen, AA; Letsoalo, T; Nchabeleng, M; Ndip, RN; Obi, CL; Sein, PP | 1 |
Aubry, A; Brossier, F; Jarlier, V; Sougakoff, W; Veziris, N | 1 |
Irfan, M; Mehfooz, Z; Rao, NA; Soomro, MM | 1 |
Ikeda, T; Ishikawa, S; Kadowaki, T; Kimura, M; Kobayashi, K; Wakabayashi, K; Yano, S | 1 |
Camara, P; Chevalier, B; Debonne, JM; Fabre, M; Gueye, M; Herve, V; Lefebvre, N; Margery, J; Mbaye, PS; Perrier-Gros-Claude, JD; Sane, M; Simon, F; Soler, C; Thiam, M | 1 |
Azevedo, V; Barnard, M; Coetzee, D; Coetzee, G; Cox, HS; Goemaere, E; McDermid, C; Muller, O; Simpson, J; van Cutsem, G | 1 |
Alffenaar, JW; de Neeling, H; Simons, S; van de Kasteele, PJ; van der Laan, T; van der Werf, TS; van Soolingen, D | 1 |
Angrup, A; Banavaliker, JN; Bose, M; Kumar, S; Pathak, RK; Sharma, H; Varma-Basil, M | 1 |
Rosilawati, ML; Yasmon, A | 1 |
Bello, T; Chirinos, G; De Donato, M; de Waard, JH; Mendoza, R; Takiff, H | 1 |
Chi, TL; Huang, WL; Jou, R; Wu, MH | 1 |
Abdurrahman, ST; Cuevas, LE; Dacombe, R; David, JS; Davies, PD; Ebisike, JN; Emenyonu, N; Lawson, L; Lawson, LO; Ouoha, JO; Parry, CM; Sogaolu, OM; Uzoewulu, GN; Yassin, MA | 1 |
Batchoun, R; Nimri, L; Samara, H | 1 |
Desai, VB; Fredrick, JS; Joseph, P; Mohan, NS; Ramachandran, R; Raman, B; Thomas, A; Wares, F | 1 |
Achawal, S; Anderson, G; Lee, WY; Ling, M; Thaker, HK | 1 |
Gallo, A; Hurwitz, M; Hwang, C; Mojtahed, A; Whitney, J | 1 |
Coulter, C; Jia, Q; Jin, Q; Li, H; Li, L; Shi, D; Zhao, Y; Zhu, G | 1 |
Chen, L; Li, N; Liu, M; Zhang, H; Zhang, J | 1 |
Hsueh, PR; Huang, YT; Lai, CC; Liao, CH; Tan, CK | 1 |
Jnawali, HN; Kim, CK; Kim, HJ; Kim, SJ; Lee, SH; Park, YK; Ryoo, SW | 1 |
Aarnoutse, R; Boeree, M; Ijdema, D; Magis-Escurra, C; van den Boogaard, J | 1 |
Baba, K; Ehlers, MM; Hoosen, AA; Ismail, NA; Kock, MM; Omar, SV; Osman, AG; Said, HM | 1 |
Borroni, E; Cabibbe, AM; Cirillo, DM; Fattorini, L; Mantegani, P; Migliori, GB; Miotto, P; Tortoli, E | 1 |
Hamilton, CD; Holland, DP; Sanders, GD; Stout, JE | 1 |
Chitnis, DS; Hemvani, N; Patidar, V | 2 |
Altpeter, E; Bodmer, T; Borrell, S; Böttger, EC; Bruderer, T; Calmy, A; Dubuis, O; Egger, M; Fehr, J; Fenner, L; Furrer, H; Gagneux, S; Jaton, K; Ninet, B; Pfyffer, GE; Siegrist, HH; Stalder, JM; Zwahlen, M | 1 |
Abdissa, A; Abdissa, K; Abebe, G; Agonafir, M; Apers, L; Colebunders, R; de-Jong, BC | 1 |
Hesseling, AC; Jordaan, A; Marais, BJ; Schaaf, HS; Seddon, JA; Victor, T | 1 |
Hassan, G; Kant, S; Parengal, J; Saheer, S | 1 |
Alcalá, L; Bouza, E; García de Viedma, D; García-Escribano Ráez, N; López-Roa, P; Ruiz-Serrano, MJ | 1 |
Allen, J; Bassett, IV; Chetty, S; Freedberg, KA; Giddy, J; Hom, JK; Losina, E; Mazibuko, M; Walensky, RP; Wang, B | 1 |
Ajbani, K; Balan, K; Boehme, C; Gray, C; Kazi, M; Nikam, C; Rodrigues, C; Shetty, A | 1 |
Bonovas, S; Lytras, T; Panagiotopoulos, T; Spala, G | 1 |
Augustynowicz-Kopeć, E; Drozd, I; Jaworski, A; Klatt, M; Kostrzewa, E; Swiderska, A; Zwolska, Z | 1 |
Rodrigues, VS; Rossetti, ML; Silva, MS; Valim, AR | 1 |
Danilova, ID; Espinal, M; Grzemska, M; Migliori, GB; Punga, VV; Raviglione, MC | 1 |
Goldberg, SV; Nolan, CM | 1 |
Agarwal, SK; Shah, AR; Shah, KV | 1 |
Martínez-Rossier, LA; Pérez-Guzmán, C; Torres-Cruz, A; Vargas, MH; Villarreal-Velarde, H | 1 |
Bjorvatn, B; Grewal, HM; Hmun, T; Htun, A; Jureen, R; Myint, H; Phyu, S; Ti, T | 1 |
Chen, TP; Chen, YH; Hwang, KP; Lee, YW; Lu, PL; Peng, CF; Tsai, JJ | 1 |
Cauchoix, B; Rakotoarisaonina, A; Rakotoherisoa, A; Rakotondramarina, D; Rakotonirina, V; Ralamboson, M; Ramarokoto, H; Rasolofo Razanamparany, V; Rasolonavalona, T; Ratsirahonana, O | 1 |
Bjune, G; Caugant, DA; Mariandyshev, A; Sandven, P; Toungoussova, OS | 1 |
BLALOCK, FA; CORPE, RF; GOLDHAMMER, EJ; GROSS, JH | 1 |
Arevalo, J; Campos, PE; Holmes, KK; Hooton, TM; Nolan, CM; Sanchez, J; Suarez, PG; Ticona, E; Zavala, D | 1 |
Bhanu, NV; Cho, SN; Gomes, HM; Jordaan, AM; Kadival, GV; Khan, BK; Kulkarni, SP; Lee, H; Lim, KC; Mokrousov, I; Narvskaya, O; Schouls, LM; Singh, UB; Suffys, PN; van Soolingen, D; Victor, TC; Yap, SF | 1 |
Cirillo, DM; Frisicale, L; Marchiaro, G; Penati, V; Piana, F; Quaranta, M; Riccabone, A; Vaccarino, P | 1 |
Johansen, IS; Lundgren, B; Marjamäki, M; Sosnovskaja, A; Thomsen, VØ | 1 |
Ito, K; Ogata, H; Wada, M; Yoshiyama, T | 1 |
Hoeppner, VH; Jones, W; Marciniuk, DD; Ward, HA | 1 |
Cicenaite, J; Davidaviciene, E; Dewan, P; Johansen, I; Laserson, K; Sosnovskaja, A; Thomsen, V; Wells, C | 1 |
Bai, YJ; Luo, M; Wang, Y; Yan, XJ; Zhang, QH; Zhao, JR | 1 |
Clobridge, A; Dormandy, J; Driscoll, J; Larsen, SC; Mirabello, L; Parsons, LM; Polletta, VL; Salfinger, M; Sanic, A; Sinyavskiy, O; Taber, HW; Zickas, G | 1 |
Avramopoulos, I; Falagas, ME; Rafailidis, PI; Sapkas, G | 1 |
Janssens, JP; Ketterer, JP; Rochat, T; Wacker, J; Younossian, AB | 1 |
Bai, GH; Koh, WJ; Kwon, OJ; Lew, WJ; Park, YK | 1 |
Alrajhi, AA | 1 |
Akgunes, A; Bilgin, K; Cetinkaya, E; Cihan, CC; Coban, AY; Durupinar, B; Uzun, M | 1 |
Andersson, J; Andersson, M; Grundström, S; Hoffner, S; Linde, C; Toro, JC | 1 |
Ano, H; Danno, K; Han, Y; Kawahara, K; Matsumoto, T; Nagai, T; Takashima, T; Tamura, Y; Tsuyuguchi, I; Yoshida, H | 1 |
Alland, D; Billman-Jacobe, H; Bobadilla del Valle, M; Bose, M; Brimacombe, M; Cavatore, M; Cave, MD; Chaves, F; Eisenach, KD; Fyfe, J; García-García, L; Guerrero, MI; Hazbón, MH; Lavender, C; León, CI; Murray, M; Ponce de León, A; Sifuentes-Osornio, J; Varma-Basil, M | 1 |
Elwood, RK; FitzGerald, JM; Moniruzzaman, A; Schulzer, M | 1 |
Baquero-Artigao, F; del Castillo, F; García-Consuegra, J; Garcia-Miguel, MJ; Merino, R | 1 |
Amirmozafari, N; Farnia, P; Ghadertotonchi, Z; Ghazi, F; Kamran, J; Masjedi, M; Mirsaedi, M; Mohammadi, F; Ramazanzadeh, R | 1 |
Aziz, MA; Htun, A; Kluge, HH; Lwin, T; Mar, TT; Maung, W; Noe, P; Paramasivan, CN; Ti, T; Wright, A | 1 |
Boloorsaz, MR; Farnia, P; Khalilzadeh, S; Safavi, A; Velayati, AA | 1 |
Bai, GH; Bai, JI; Chang, CL; Choi, YW; Kim, HJ; Kim, SJ; Lee, JK; Park, YK | 1 |
Augustynowicz-Kopeć, E; Zwolska, Z | 1 |
Bed, ST; Chottanapund, S; Eampokalap, B; Manosuthi, W; Sungkanuparph, S | 1 |
Fissette, K; Kabedi, MJ; Kashongwe, M; Kayembe, JM; Mampasi, P; Mbaya, P; Mumba Ngoyi, D; Muyembe-Tamfum, JJ; Portaels, F; Verhaegen, J | 1 |
Al-Absi, AN; Al-Akhali, A; Fujiki, A; Masui, T; Mitarai, S; Mori, T; Ohkado, A; Otomo, K; Seita, A; Yamada, H; Yamada, N | 1 |
Chandramuki, A; Mani, R; Nagarathna, S; Rafi, W; Satishchandra, P; Veenakumari, HB | 1 |
Chung, MP; Kim, H; Kim, YH; Koh, WJ; Kwon, OJ; Lim, SY; Suh, GY | 1 |
Dhingra, VK; Hanif, M; Mittal, A; Rajpal, S | 1 |
Berning, SE; Elliott, AM; Iseman, MD; Peloquin, CA | 1 |
Nelson, SD; Nolan, CM; Sandblom, RE; Slattery, JT; Thummel, KE | 1 |
Angarano, G; Carbonara, D; Costa, D | 1 |
Kroegel, C; Schrappe, M; Wassermann, K | 1 |
Hill, AR; Hudak, A; Mateo, F | 1 |
Karagöz, T; Kizkin, O; Partal, M; Sadoğlu, T; Tahaoğlu, K; Tor, M | 1 |
Alfalla, C; Butler, WR; Haas, WH; Hewlett, D; Horn, DL; Levine, A; Nayak, A; Opal, SM; Tan, E | 1 |
Gusset, T; Rieder, HL; Salfinger, M | 1 |
Bonk, S; Bromberg, A; Bromberg, R; Hanna, BA; Neville, K; Rom, WN | 1 |
Gupta, PR; Gupta, RB; Sharma, TN; Singhal, B | 1 |
Birnbaum, J; Chan, SP; Rao, M; Steiner, P | 1 |
Aita, J; Barrera, L; Biglione, J; Largacha, C; Lopez, B; Rajmil, JC; Reniero, A; Ritacco, V; Weisburd, G | 1 |
Alland, D; Brudney, K; Crawford, JT; Frieden, TR; Fujiwara, PI; Hewlett, D; Kreisworth, BN; Maw, KL; Nivin, B; Sharp, V; Sherman, LF | 1 |
Braun, TW; Hilton, E; Ruggiero, SL | 1 |
Coker, RJ; Fisher, M; Tomlinson, DR | 1 |
Bustreo, F; Laszlo, A; Rahman, M; Raviglione, M | 1 |
Berhane, Y; Demissie, M; Gebeyehu, M | 1 |
Kuś, J; Michałowska-Mitczuk, D | 2 |
Boudville, IC; Snodgrass, I; Wong, SY | 1 |
Dautzenberg, B; Jouveshomme, S | 1 |
Mitchison, DA | 1 |
Finelli, L; Liu, Z; Shilkret, KL | 1 |
Binkin, N; Bustreo, F; Chaulet, P; Cohn, DL; Kim, SJ; Lambregts-van Weezenbeek, CS; Laszlo, A; Nunn, P; Pablos-Méndez, A; Raviglione, MC; Rieder, HL | 1 |
Gallemore, GH; Mehta, JB; Mejia, E; Ramsey, GF | 1 |
Barrow, WW; Goh, KS; Horgen, L; Rastogi, N | 1 |
Barrera, L; de Kantor, IN; Latini, O | 1 |
Fodor, T; Lõrinczi, I; Vadász, I | 1 |
Bercion, R; Kuaban, C | 1 |
Abate, G; Miörner, H | 1 |
Baello, BQ; Balagtas, ED; Cardano, RC; Co, VM; Mantala, MJ; Pascual, LG; Quelapio, ID; Rivera, AB; Tupasi, TE; Villa, LA | 1 |
Coninx, R; de Haller, R; Debacker, M; Ismaelov, A; Mathieu, C; Meddings, DR; Mirzoev, F | 1 |
Long, R; Scalcini, M | 1 |
Bartsch, P; Corhay, JL; Gach, O; Lousberg, L | 1 |
Musser, JM; Ramaswamy, S | 1 |
Aleixo-Dias, J; Antunes, AF; Antunes, ML; Pereira, MF; Raymundo, E; Rodrigues, MF | 1 |
Baéz, J; Dye, C; Espinal, MA; Kam, KM; Khomenko, AG; Kim, SJ; Kochi, A; Migliori, GB; Raviglione, MC; Suarez, PG | 1 |
Achi, V; Coulibaly, G; Diagbouga, S; Domoua, K; N'Dathz, M; Ouedraogo, M; Ouedraogo, SM; Yapi, A | 1 |
Chagaluka, S; Drobniewski, F; Fine, PE; Glynn, JR; Jenkins, PA; Ngwira, B; Pönnighaus, JM; Warndorff, DK; Yates, M | 1 |
Taniguchi, H | 1 |
Ewa, AK; Magdalena, K; Zofia, Z | 1 |
Aguar Benito, MC; Arnedo Pena, A; González Morán, F; Marín Royo, M; Moreno Muñoz, R; Pardo Serrano, F; Prada Alfaro, P | 1 |
Arnadottir, T; Enarson, DA; Rieder, HL; Trébucq, A | 1 |
Khan, MY; Kinsara, AJ; Memish, Z; Osoba, AO; Samman, Y; Wali, S | 1 |
Kam, KM; Yip, CW | 1 |
Antunes, ML; Binkin, N; Camacho, M; Espinal, MA; Fusheng, Z; George, AG; Kim, SJ; Laserson, K; Martin-Casabona, N; Raviglione, MC; Simelane, P; Smith, I; Suarez, P; Tlali, RE; Weyer, K | 1 |
Al-Marri, MR | 1 |
Ding, D; Duanmu, HJ; Li, D; Peng, YL; Song, H; Wang, G; Wang, L; Xing, J; Zhang, G; Zhang, L; Zhang, Z | 1 |
Al-Sayegh, MO; Al-Sharif, N; Osman, MM; Shaikh, MA; Singla, R | 1 |
Krevans, JR | 1 |
19 review(s) available for ethambutol and Tuberculosis, Drug-Resistant
Article | Year |
---|---|
Isoniazid derivatives and their anti-tubercular activity.
Topics: Animals; Antitubercular Agents; Drug Discovery; Humans; Isoniazid; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2017 |
Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) in the detection of drug resistance of Mycobacterium tuberculosis in re-treated patients.
Topics: Antitubercular Agents; Drug Resistance; Ethambutol; Humans; Isoniazid; Lasers; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptomycin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2022 |
The Changing Paradigm of Drug-Resistant Tuberculosis Treatment: Successes, Pitfalls, and Future Perspectives.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
Tuberculosis treatment in children: The changing landscape.
Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Central Nervous System; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2020 |
Tuberculosis in 2019.
Topics: Antitubercular Agents; Ethambutol; Health Policy; Humans; India; Isoniazid; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Practice Guidelines as Topic; Pulmonologists; Pyrazinamide; Rifampin; Surveys and Questionnaires; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization | 2020 |
Mycobacterial ethambutol responsive genes and implications in antibiotics resistance.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Resistance, Bacterial; Ethambutol; Genes, Bacterial; Humans; Mutation; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2021 |
Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.
Topics: Antitubercular Agents; Cost-Benefit Analysis; Disease Progression; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Humans; Latent Tuberculosis; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2017 |
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis.
Topics: Antibiotics, Antitubercular; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Observational Studies as Topic; Outcome Assessment, Health Care; Pyrazinamide; Randomized Controlled Trials as Topic; Review Literature as Topic; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
Development of new drug-regimens against multidrug-resistant tuberculosis.
Topics: Adamantane; Antitubercular Agents; Diarylquinolines; Drug Development; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Ethylenediamines; Humans; Isoniazid; Macrolides; Medication Adherence; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 2019 |
A meta-analysis of drug resistant tuberculosis in Sub-Saharan Africa: how strongly associated with previous treatment and HIV co-infection?
Topics: Adolescent; Adult; Africa South of the Sahara; Aged; Aged, 80 and over; Antitubercular Agents; Child; Coinfection; Ethambutol; Female; HIV Infections; Humans; Male; Middle Aged; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult | 2013 |
Antitubercular therapy in patients with cirrhosis: challenges and options.
Topics: Antitubercular Agents; Ethambutol; Humans; Immune System Diseases; Isoniazid; Latent Tuberculosis; Liver; Liver Cirrhosis; Liver Diseases; Liver Failure; Liver Function Tests; Liver Transplantation; Prevalence; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2014 |
Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm.
Topics: Antitubercular Agents; Diarylquinolines; Drug Design; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Evolution, Chemical; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2015 |
Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.
Topics: Africa South of the Sahara; Antitubercular Agents; Bacteriological Techniques; Ethambutol; Humans; Isoniazid; Prevalence; Rifampin; Risk Factors; Streptomycin; Tuberculosis, Multidrug-Resistant; World Health Organization | 2015 |
Diagnosis of Drug Resistance to Fluoroquinolones, Amikacin, Capreomycin, Kanamycin and Ethambutol with Genotype MTBDRsl Assay: a Meta-Analysis.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Genotyping Techniques; Humans; Kanamycin; Kanamycin Resistance; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2015 |
Anti-tuberculosis drug resistance in Ethiopia: systematic review.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethiopia; Humans; Isoniazid; Prevalence; Public Health; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2017 |
[Resistant tuberculosis: a molecular review].
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2002 |
[Antitubercular chemotherapy].
Topics: Aged; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Clinical Protocols; Drug Combinations; Ethambutol; Follow-Up Studies; HIV Seronegativity; Humans; Isoniazid; Patient Compliance; Patient Education as Topic; Pyrazinamide; Rifampin; Treatment Failure; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cycloserine; Drug Resistance, Multiple; Ethambutol; Ethionamide; Fluoroquinolones; Genes, Bacterial; Isoniazid; Mutation; Mycobacterium tuberculosis; Polymorphism, Genetic; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Virulence | 1998 |
[Molecular mechanisms of multidrug resistance in Mycobacterium tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Multiple; Ethambutol; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2000 |
10 trial(s) available for ethambutol and Tuberculosis, Drug-Resistant
Article | Year |
---|---|
Treatment Strategy for Rifampin-Susceptible Tuberculosis.
Topics: Antitubercular Agents; Diarylquinolines; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Linezolid; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2023 |
Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV: A Randomized Clinical Trial.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; CD4 Lymphocyte Count; Directly Observed Therapy; Drug Administration Schedule; Ethambutol; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Isoniazid; Male; Middle Aged; Patient Dropouts; Proportional Hazards Models; Rifampin; Streptomycin; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Viral Load | 2018 |
Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Substitution; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Linezolid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2019 |
Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014.
Topics: Adolescent; Adult; Child; Child, Preschool; Cross-Sectional Studies; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Levofloxacin; Male; Middle Aged; Peru; Pyrazinamide; Retrospective Studies; Rifampin; Sex Factors; Time Factors; Tuberculosis, Multidrug-Resistant | 2018 |
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial.
Topics: Antitubercular Agents; Bangladesh; Clinical Protocols; Clofazimine; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Moxifloxacin; Prothionamide; Pyrazinamide; Research Design; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
Results at 30 months of a randomised trial of FDCs and separate drugs for the treatment of tuberculosis.
Topics: Africa; Antitubercular Agents; Asia; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Latin America; Male; Pyrazinamide; Recurrence; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pul
Topics: Adolescent; Adult; Antitubercular Agents; Colony Count, Microbial; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Male; Moxifloxacin; Nitroimidazoles; Pyrazinamide; Rifampin; South Africa; Sputum; Tanzania; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India.
Topics: Adult; Antibiotics, Antitubercular; Communicable Disease Control; Cycloserine; Directly Observed Therapy; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Ethionamide; Female; Humans; India; Kanamycin; Male; Middle Aged; Ofloxacin; Prospective Studies; Pyrazinamide; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2011 |
Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
[Multicenter transversal study of tuberculosis and drug resistance in Madrid (October 1993-April 1994)].
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Spain; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
257 other study(ies) available for ethambutol and Tuberculosis, Drug-Resistant
Article | Year |
---|---|
Prevalence of and molecular basis for tuberculosis drug resistance in the Republic of Georgia: validation of a QIAplex system for detection of drug resistance-related mutations.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Ethambutol; Georgia (Republic); Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Prevalence; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis, Multidrug-Resistant | 2008 |
Simple dihydrosphyngosine analogues with potent activity against MDR-Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Sphingosine; Tuberculosis, Multidrug-Resistant | 2009 |
Antimycobacterial activity of bisbenzylisoquinoline alkaloids from Tiliacora triandra against multidrug-resistant isolates of Mycobacterium tuberculosis.
Topics: Alkaloids; Antitubercular Agents; Benzylisoquinolines; Drug Resistance, Multiple, Bacterial; Humans; Magnetic Resonance Spectroscopy; Menispermaceae; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Plant Extracts; Plant Roots; Tuberculosis, Multidrug-Resistant | 2012 |
Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis.
Topics: Animals; Antitubercular Agents; Cell Line; Cyclic N-Oxides; Drug Resistance, Multiple, Bacterial; Latent Tuberculosis; Mice; Mycobacterium tuberculosis; Quinoxalines; Tuberculosis, Multidrug-Resistant | 2016 |
Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Imidazoles; Molecular Structure; Mycobacterium tuberculosis; Nitrofurans; Structure-Activity Relationship; Tuberculosis, Multidrug-Resistant | 2018 |
Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis.
Topics: Amides; Animals; Antitubercular Agents; Cell Line; Chemistry, Pharmaceutical; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2019 |
Design, synthesis, and evaluation of substituted 2-acylamide-1,3-benzo[d]zole analogues as agents against MDR- and XDR-MTB.
Topics: Animals; Antitubercular Agents; Drug Design; Female; Halogenation; HEK293 Cells; Humans; Male; Mice; Mycobacterium tuberculosis; Oxazoles; Rats, Sprague-Dawley; Thiadiazoles; Tuberculosis, Multidrug-Resistant | 2021 |
Identification of nitrofuranylchalcone tethered benzoxazole-2-amines as potent inhibitors of drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy.
Topics: Amines; Animals; Antitubercular Agents; Benzoxazoles; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrofurans; Tuberculosis; Tuberculosis, Multidrug-Resistant; Vero Cells | 2022 |
Antimycobacterial compound of chitosan and ethambutol: ultrastructural biological evaluation in vitro against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Chitosan; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2021 |
Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Bangladesh; DNA, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Female; Genotype; Genotyping Techniques; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2021 |
Seizures and sideroblastic anaemia in a patient with multidrug-resistant tuberculosis.
Topics: Anemia, Sideroblastic; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Fatigue; Hemoglobins; Humans; Linezolid; Magnetic Resonance Imaging; Male; Middle Aged; Seizures; Tuberculosis, Multidrug-Resistant | 2022 |
Characterization of embB mutations involved in ethambutol resistance in multi-drug resistant Mycobacterium tuberculosis isolates in Zambia.
Topics: Antitubercular Agents; Ethambutol; Humans; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pentosyltransferases; Tuberculosis, Multidrug-Resistant; Zambia | 2022 |
Use of Whole-Genome Sequencing to Predict
Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Drug Resistance; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2022 |
Intracellular Activity of Poly (DL-Lactide-co-Glycolide) Nanoparticles Encapsulated with Prothionamide, Pyrazinamide, Levofloxacin, Linezolid, or Ethambutol on Multidrug-Resistant
Topics: Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Humans; Levofloxacin; Linezolid; Mycobacterium tuberculosis; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Prothionamide; Pyrazinamide; Reactive Oxygen Species; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2023 |
Prevalence and Drug Resistance Pattern of
Topics: Adolescent; Adult; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Iraq; Isoniazid; Mycobacterium tuberculosis; Prevalence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2022 |
Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethiopia; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2022 |
Comparison of different regimens with or without fluoroquinolone in isoniazid-resistant tuberculosis: A multicenter cohort study.
Topics: Antitubercular Agents; Cohort Studies; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant | 2022 |
Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru.
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peru; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2022 |
Evaluation of whole-genome sequence to predict drug resistance of nine anti-
Topics: Antitubercular Agents; Drug Resistance; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2022 |
The second national anti-tuberculosis drug resistance survey in Tanzania, 2017-2018.
Topics: Antitubercular Agents; Cross-Sectional Studies; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tanzania; Tuberculosis, Multidrug-Resistant | 2022 |
Distribution and Pattern of Anti-Tubercular Drug Resistance in Patients with Pulmonary Tuberculosis in Mymensingh Region of Bangladesh.
Topics: Antitubercular Agents; Bangladesh; Cross-Sectional Studies; Drug Resistance; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2022 |
Development and Assessment of a Novel Whole-Gene-Based Targeted Next-Generation Sequencing Assay for Detecting the Susceptibility of Mycobacterium tuberculosis to 14 Drugs.
Topics: Amikacin; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; High-Throughput Nucleotide Sequencing; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2022 |
[An atypical presentation of tuberculosis].
Topics: Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
GenoType MTBDRsl for detection of second-line drugs and ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis isolates at a high-throughput laboratory.
Topics: Aminoglycosides; Antitubercular Agents; Brazil; Capreomycin; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Genotype; Genotyping Techniques; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2023 |
Metabolomic analysis of Mycobacterium tuberculosis reveals metabolic profiles for identification of drug-resistant tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Extensively Drug-Resistant Tuberculosis; Humans; Metabolome; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tandem Mass Spectrometry; Tuberculosis, Multidrug-Resistant | 2023 |
In vitro bioevaluation and docking study of dihydrosphingosine and ethambutol analogues against sensitive and multi-drug resistant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Sphingosine; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2023 |
Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Latvia; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2023 |
Interactive effect of oral anti-hyperglycaemic or anti-hypertensive drugs on the inhibitory and bactericidal activity of first line anti-TB drugs against M. tuberculosis.
Topics: Antihypertensive Agents; Antitubercular Agents; Diabetes Mellitus; Ethambutol; Humans; Hypertension; Hypoglycemic Agents; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pharmaceutical Preparations; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2023 |
First-line anti-tuberculosis drug resistance trends of Mycobacterium tuberculosis complex isolates. A tertiary hospital study in Turkey.
Topics: Adolescent; Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Public Health; Rifampin; Sputum; Streptomycin; Tertiary Care Centers; Tuberculosis, Multidrug-Resistant; Turkey; Young Adult | 2019 |
Multiplex PCR for Rapid Diagnosis of Drug Resistant Mycobacterium Tuberculosis.
Topics: Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Multiplex Polymerase Chain Reaction; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2019 |
[Tuberculosis].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2019 |
The molecular patterns of resistance to anti-tuberculosis drugs: an analysis from Istanbul, Turkey.
Topics: Adult; Aminoglycosides; Antitubercular Agents; Ethambutol; Female; Fluoroquinolones; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Phenotype; Rifampin; Tuberculosis, Multidrug-Resistant; Turkey | 2020 |
Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Ethambutol; France; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pentosyltransferases; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Whole Genome Sequencing | 2020 |
Risk Factors for Adverse Events in Household Contacts Prescribed Preventive Treatment for Drug-resistant Tuberculosis Exposure.
Topics: Antitubercular Agents; Ethambutol; Fluoroquinolones; Humans; Pakistan; Risk Factors; Tuberculosis, Multidrug-Resistant | 2021 |
Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Capreomycin; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Genetic Variation; Genotype; Humans; Iran; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2020 |
Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bangladesh; Child; Child, Preschool; Clinical Protocols; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
Tuberculosis drug resistance in Canakkale, Turkey.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Turkey | 2020 |
Management of isoniazid-monoresistant tuberculosis (Hr-TB) in Queensland, Australia: a retrospective case series.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Australia; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Ethinyl Estradiol-Norgestrel Combination; Female; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
Treatment Outcomes and Adverse Drug Effects of Ethambutol, Cycloserine, and Terizidone for the Treatment of Multidrug-Resistant Tuberculosis in South Africa.
Topics: Adult; Antitubercular Agents; Cycloserine; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Isoxazoles; Oxazolidinones; Pharmaceutical Preparations; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2020 |
Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB.
Topics: Adult; Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2020 |
Effectiveness of Shorter Treatment Regimen in Multidrug-Resistant Tuberculosis Patients in Pakistan: A Multicenter Retrospective Record Review.
Topics: Adult; Amikacin; Antitubercular Agents; Clofazimine; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Lost to Follow-Up; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Pakistan; Pyrazinamide; Retrospective Studies; Survival Analysis; Treatment Failure; Tuberculosis, Multidrug-Resistant | 2021 |
Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Fluoroquinolones; Humans; Kuwait; Male; Mycobacterium tuberculosis; Prevalence; Tuberculosis, Multidrug-Resistant | 2021 |
The Rate of Drug-Resistant Tuberculosis in Korean Children and Adolescents Since 2007.
Topics: Adolescent; Antitubercular Agents; Asian People; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Incidence; Infant; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Republic of Korea; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Combinations; Ethambutol; HIV Infections; Humans; Isoniazid; Male; Metabolic Clearance Rate; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2017 |
Molecular detection of Isoniazid, Rifampin and Ethambutol resistance to M. tuberculosis and M. bovis in multidrug resistant tuberculosis (MDR-TB) patients in Pakistan.
Topics: Adolescent; Adult; Aged; Bacterial Proteins; Child; DNA-Directed RNA Polymerases; DNA, Bacterial; Ethambutol; Genes, Bacterial; Histones; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Mutation; Mycobacterium bovis; Mycobacterium tuberculosis; Pakistan; Pathology, Molecular; Pentosyltransferases; Rifampin; Risk Factors; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis.
Topics: Antitubercular Agents; Base Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Genetic Variation; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mitoxantrone; Molecular Docking Simulation; Mutation; Mycobacterium tuberculosis; Ofloxacin; Phenotype; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Rifampin; Sequence Analysis; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2017 |
Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis.
Topics: Adult; Age Distribution; Aged; Alcohol Drinking; Aminosalicylic Acid; Antitubercular Agents; Cohort Studies; Comorbidity; Cycloserine; Ethambutol; Female; Fluoroquinolones; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Prothionamide; Pyrazinamide; Republic of Korea; Retrospective Studies; Rifampin; Severity of Illness Index; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Trends and characteristics of drug-resistant tuberculosis in rural Shandong, China.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; China; Ethambutol; Female; Follow-Up Studies; Humans; Infant; Isoniazid; Logistic Models; Male; Middle Aged; Prevalence; Retrospective Studies; Rifampin; Rural Population; Streptomycin; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
Biological evaluation of novel curcumin-pyrazole-mannich derivative active against drug-resistant Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Bacterial Load; Curcumin; Disease Models, Animal; Drug Combinations; Drug Synergism; Ethambutol; Female; Humans; Mannich Bases; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Pyrazoles; Time Factors; Tuberculosis, Multidrug-Resistant | 2017 |
Prescription practice of anti-tuberculosis drugs in Yunnan, China: A clinical audit.
Topics: Adult; Aged; Antitubercular Agents; Asian People; China; Clinical Audit; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Male; Middle Aged; Outcome Assessment, Health Care; Prescriptions; Pyrazinamide; Retreatment; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Secretome profile analysis of multidrug-resistant, monodrug-resistant and drug-susceptible Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Gene Expression Profiling; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Proteomics; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.
Topics: Anti-HIV Agents; Antitubercular Agents; Child; Drug Administration Schedule; Drug Combinations; Drug Interactions; Ethambutol; Female; HIV; HIV Infections; Humans; Isoniazid; Lopinavir; Male; Models, Statistical; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Ritonavir; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
Outcomes of pulmonary tuberculosis in patients with discordant phenotypic isoniazid resistance testing.
Topics: Aged; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Nucleic Acid Synthesis Inhibitors; Pyrazinamide; Republic of Korea; Retrospective Studies; Rifampin; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Machine learning for classifying tuberculosis drug-resistance from DNA sequencing data.
Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Machine Learning; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
Topics: Antitubercular Agents; Ethambutol; Genes, Bacterial; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
Drug resistant tuberculosis in Saudi Arabia: an analysis of surveillance data 2014-2015.
Topics: Adult; Age Factors; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Regression Analysis; Retrospective Studies; Rifampin; Saudi Arabia; Sex Factors; Streptomycin; Tuberculosis, Multidrug-Resistant; World Health Organization; Young Adult | 2018 |
Molecular epidemiology and drug sensitivity pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in and around Ambo Town, Central Ethiopia.
Topics: Adolescent; Adult; Cross-Sectional Studies; Ethambutol; Ethiopia; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Mycobacterium tuberculosis; Rifampin; RNA, Viral; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2018 |
Prevalence and patterns of drug resistance among pulmonary tuberculosis patients in Hangzhou, China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; China; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2018 |
Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique.
Topics: Antitubercular Agents; Cross-Sectional Studies; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2018 |
Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
Topics: Antitubercular Agents; Ethambutol; Ethiopia; Female; HIV Infections; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Risk Factors; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
TB-EFI, a novel 18-Plex microbead-based method for prediction of second-line drugs and ethambutol resistance in Mycobacterium tuberculosis complex.
Topics: Alleles; Antitubercular Agents; Diagnostic Tests, Routine; DNA, Bacterial; Ethambutol; Fluoroquinolones; Genotype; Genotyping Techniques; Humans; Microbial Sensitivity Tests; Microfluidics; Microspheres; Mutation; Mycobacterium tuberculosis; Pentosyltransferases; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2018 |
Drug resistance pattern in Mycobacterium tuberculosis to the first line drugs of pulmonary tuberculosis patients at Hazara Region, Pakistan.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pakistan; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis.
Topics: Adjuvants, Immunologic; Anti-Bacterial Agents; Antitubercular Agents; Cell Line; Drug Therapy, Combination; Ethambutol; Glutathione; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; THP-1 Cells; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2018 |
Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study.
Topics: Adult; Antitubercular Agents; Coinfection; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; HIV; HIV Infections; Humans; Isoniazid; Isoxazoles; Levofloxacin; Male; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Retrospective Studies; South Africa; Survival Analysis; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2019 |
Predicting the Outcomes of New Short-Course Regimens for Multidrug-Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modeling.
Topics: Antitubercular Agents; Clofazimine; Colony Count, Microbial; Computer Simulation; Diarylquinolines; Dose-Response Relationship, Drug; Drug Dosage Calculations; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Host-Pathogen Interactions; Humans; Immunity, Innate; Isoniazid; Kanamycin; Macrophages; Microbial Sensitivity Tests; Models, Statistical; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Prothionamide; Pyrazinamide; Time Factors; Tuberculosis, Multidrug-Resistant | 2018 |
Mutations of Mycobacterium tuberculosis induced by anti-tuberculosis treatment result in metabolism changes and elevation of ethambutol resistance.
Topics: Antitubercular Agents; Carbohydrate Metabolism; Drug Resistance, Multiple, Bacterial; Energy Metabolism; Ethambutol; Humans; Metabolic Networks and Pathways; Metabolomics; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2019 |
Potentially High Number of Ineffective Drugs with the Standard Shorter Course Regimen for Multidrug-Resistant Tuberculosis Treatment in Haiti.
Topics: Adult; Antitubercular Agents; Coinfection; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; Fluoroquinolones; Haiti; HIV; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2019 |
Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Ethambutol; Genotype; Humans; Incidence; Isoniazid; Kuwait; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 2019 |
Direct drug susceptibility testing of Mycobacterium tuberculosis using the proportional method: A multicenter study.
Topics: Antitubercular Agents; Bacteriological Techniques; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Iran; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2019 |
Isoniazid-Resistant Rifampicin-Susceptible Tuberculosis in Children.
Topics: Antitubercular Agents; Child; Child, Preschool; Contact Tracing; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Spain; Tuberculosis, Multidrug-Resistant | 2019 |
Association of ubiA mutations and high-level of ethambutol resistance among Mycobacterium tuberculosis Thai clinical isolates.
Topics: Antitubercular Agents; Bacterial Proteins; DNA, Bacterial; Drug Resistance, Bacterial; Ethambutol; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phosphotransferases (Phosphate Group Acceptor); Phylogeny; Tuberculosis, Multidrug-Resistant | 2019 |
Whole-Genome Sequencing for Drug Resistance Profile Prediction in
Topics: Antitubercular Agents; Democratic Republic of the Congo; Drug Resistance, Multiple, Bacterial; Ethambutol; Genome, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Peru; Phenotype; Switzerland; Thailand; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2019 |
Distribution of embB mutations of Thai clinical isolates of ethambutol-resistant Mycobacterium tuberculosis.
Topics: Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Mutation; Mycobacterium tuberculosis; Pentosyltransferases; Prevalence; Sequence Analysis, DNA; Thailand; Tuberculosis, Multidrug-Resistant | 2019 |
First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Emigrants and Immigrants; Ethambutol; Female; Germany; Humans; Infant; Isoniazid; Logistic Models; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Prevalence; Public Health Surveillance; Pyrazinamide; Rifampin; Risk Factors; Streptomycin; Tuberculosis, Multidrug-Resistant | 2019 |
Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005-2015.
Topics: Adult; Aged; Antitubercular Agents; Ethambutol; Humans; Incidence; Isoniazid; Logistic Models; Middle Aged; Netherlands; Pyrazinamide; Registries; Retrospective Studies; Rifampin; Risk Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2019 |
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Logistic Models; London; Male; Middle Aged; Practice Guidelines as Topic; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Treatment Failure; Tuberculosis, Multidrug-Resistant; World Health Organization; Young Adult | 2019 |
Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Resistance, Bacterial; Epidemiological Monitoring; Ethambutol; Female; Health Surveys; Humans; Incidence; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Risk Factors; Saudi Arabia; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
Isoniazid- and streptomycin-resistant miliary tuberculosis complicated by intracranial tuberculoma in a Japanese infant.
Topics: Antitubercular Agents; Drug Substitution; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Humans; Infant; Isoniazid; Microbial Sensitivity Tests; Pyrazinamide; Radiography, Thoracic; Rifampin; Streptomycin; Treatment Outcome; Tuberculoma, Intracranial; Tuberculosis, Miliary; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
Topics: Acetyltransferases; Amidohydrolases; Amikacin; Antigens, Bacterial; Bacterial Proteins; Capreomycin; Catalase; DNA Gyrase; DNA Primers; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Genetic Loci; Humans; Isoniazid; Kanamycin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Oxidoreductases; Pentosyltransferases; Polymerase Chain Reaction; Promoter Regions, Genetic; Pyrazinamide; Republic of Korea; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2013 |
Epidemiology of isoniazid resistance mutations and their effect on tuberculosis treatment outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Bacterial Proteins; Catalase; Codon; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Follow-Up Studies; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Promoter Regions, Genetic; Recurrence; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Vietnam; Young Adult | 2013 |
Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection.
Topics: Aged; Antitubercular Agents; Coinfection; Culture Techniques; Delayed Diagnosis; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Minisatellite Repeats; Molecular Diagnostic Techniques; Multilocus Sequence Typing; Mycobacterium tuberculosis; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
Comparing cost-effectiveness of standardised tuberculosis treatments given varying drug resistance.
Topics: Blindness; Cost-Benefit Analysis; Decision Trees; Drug Resistance, Bacterial; Ethambutol; Health Care Costs; Humans; Isoniazid; Markov Chains; Prevalence; Probability; Quality-Adjusted Life Years; Sensitivity and Specificity; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization | 2014 |
Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study.
Topics: Antitubercular Agents; Child, Preschool; Ethambutol; Female; HIV Infections; Humans; Infant; Infant, Newborn; Isoniazid; Male; Ofloxacin; Prospective Studies; Risk Factors; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2013 |
Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method.
Topics: Antitubercular Agents; Drug Combinations; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ethambutol; Humans; Indicators and Reagents; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium tuberculosis; Oxazines; Tuberculosis; Tuberculosis, Multidrug-Resistant; Xanthenes | 2013 |
[Evaluation of multidrug-resistant tuberculosis treatment in Ivory Coast from 2008 to 2010].
Topics: Adult; Antitubercular Agents; Cote d'Ivoire; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Female; Hospitals, University; Humans; Isoniazid; Male; Medication Adherence; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant; Withholding Treatment; Young Adult | 2013 |
Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clone Cells; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Operon; Phylogeny; Polymorphism, Restriction Fragment Length; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vietnam | 2013 |
Mutations in the embB gene and their association with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates from Poland.
Topics: Adult; Aged; Base Sequence; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Pentosyltransferases; Tuberculosis, Multidrug-Resistant | 2013 |
Antitubercular drug-induced violent suicide of a hospitalised patient.
Topics: Antitubercular Agents; Cycloserine; Drug Therapy, Combination; Ethambutol; Heart Injuries; Hospitalization; Humans; India; Levofloxacin; Male; Psychoses, Substance-Induced; Self-Injurious Behavior; Suicide; Tuberculosis, Multidrug-Resistant; Violence; Wounds, Stab; Young Adult | 2014 |
Ethambutol resistance as determined by broth dilution method correlates better than sequencing results with embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Genotyping Techniques; Humans; Microbial Sensitivity Tests; Mutation, Missense; Mycobacterium tuberculosis; Pentosyltransferases; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2014 |
Multidrug-resistant tuberculosis in Western Australia, 1998-2012.
Topics: Adolescent; Adult; Antitubercular Agents; Aza Compounds; Case-Control Studies; Child; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Hospitalization; Humans; Isoniazid; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Retrospective Studies; Risk Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Western Australia; Young Adult | 2014 |
Cervical lymphadenopathy--pitfalls of blind antitubercular treatment.
Topics: Adolescent; Adult; Antitubercular Agents; Biopsy; Diagnostic Errors; Ethambutol; Female; Histiocytic Necrotizing Lymphadenitis; Hodgkin Disease; Humans; India; Isoniazid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
Evaluation of a microcolony growth monitoring method for the rapid determination of ethambutol resistance in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2014 |
Rapid molecular screening for multidrug-resistant tuberculosis in a resource-limited region of China.
Topics: Antitubercular Agents; Bacterial Proteins; China; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Genes, Bacterial; Humans; Kanamycin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Phenotype; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2014 |
High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses.
Topics: Adolescent; Adult; Aged; Body Mass Index; Body Weight; Clofazimine; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Fluoroquinolones; Follow-Up Studies; Gatifloxacin; HIV Infections; Humans; Kanamycin; Male; Middle Aged; Niger; Prospective Studies; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
Treatment options and outcomes of hospitalised tuberculosis patients: a nationwide study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Ethambutol; Female; Hospital Mortality; Hospitalization; Humans; Infant; Infant, Newborn; Isoniazid; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Patient Discharge; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
Analysis of embCAB mutations associated with ethambutol resistance in multidrug-resistant mycobacterium tuberculosis isolates from China.
Topics: Antitubercular Agents; Bacterial Proteins; China; DNA, Bacterial; Ethambutol; Humans; Membrane Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pentosyltransferases; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2015 |
[The therapeutic effect of regimens containing isoniazid and rifampicin for pulmonary tuberculosis with single isoniazid or rifampicin resistance].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Retreatment; Retrospective Studies; Rifampin; Sputum; Thorax; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2014 |
Profile of adverse drug reactions in drug resistant tuberculosis from Punjab.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Arthralgia; Ataxia; Chemical and Drug Induced Liver Injury; Child; Cycloserine; Drug Eruptions; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Gastrointestinal Diseases; Hearing Loss; Humans; Hypothyroidism; India; Kanamycin; Levofloxacin; Male; Middle Aged; Peripheral Nervous System Diseases; Psychoses, Substance-Induced; Pyrazinamide; Severity of Illness Index; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vision Disorders; Young Adult | 2014 |
High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cameroon; Clofazimine; Cohort Studies; Confidence Intervals; Developing Countries; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Isoniazid; Kanamycin; Male; Medication Adherence; Middle Aged; Odds Ratio; Prospective Studies; Prothionamide; Pyrazinamide; Risk Assessment; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2015 |
Tetrandrine reverses drug resistance in isoniazid and ethambutol dual drug-resistant Mycobacterium tuberculosis clinical isolates.
Topics: Antitubercular Agents; Benzylisoquinolines; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2015 |
Epidemiological Characterization of Drug Resistance among Mycobacterium tuberculosis Isolated from Patients in Northeast of Iran during 2012-2013.
Topics: Adolescent; Adult; Drug Resistance; Ethambutol; Female; Humans; Iran; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Rifampin; Tuberculosis, Multidrug-Resistant | 2015 |
Possible association of rare polymorphism in the ABCB1 gene with rifampin and ethambutol drug-resistant tuberculosis.
Topics: Adult; Antitubercular Agents; ATP Binding Cassette Transporter, Subfamily B; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Gene Frequency; Genetic Association Studies; Haplotypes; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Phenotype; Polymorphism, Genetic; Rifampin; Risk Factors; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2015 |
Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethiopia; Female; Hospitals, Public; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prevalence; Retreatment; Rifampin; Risk Assessment; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
Mutation at embB codon 306, a potential marker for the identification of multidrug resistance associated with ethambutol in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Ethambutol; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pentosyltransferases; Tuberculosis, Multidrug-Resistant | 2015 |
Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Female; Genetic Variation; Genotype; Humans; Indonesia; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
Reduced turn-around time for Mycobacterium tuberculosis drug susceptibility testing with a proportional agar microplate assay.
Topics: Agar; Antitubercular Agents; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Ethambutol; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2015 |
Determinants of the Sympatric Host-Pathogen Relationship in Tuberculosis.
Topics: Adolescent; Adult; Age Factors; Aged; Antitubercular Agents; Child; Child, Preschool; DNA, Intergenic; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Genotype; HIV Infections; Host-Pathogen Interactions; Humans; Infant; Infant, Newborn; Isoniazid; Male; Middle Aged; Molecular Epidemiology; Mycobacterium tuberculosis; Phylogeography; Portugal; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; China; Cohort Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2016 |
Epidemiology and Clinical Characteristics of Pediatric Drug-Resistant Tuberculosis in Chongqing, China.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; China; Cross-Sectional Studies; Ethambutol; Female; Humans; Infant; Isoniazid; Logistic Models; Male; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
Epidemiological Trends of Drug-Resistant Tuberculosis in China From 2007 to 2014: A Retrospective Study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; China; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Middle Aged; Regression Analysis; Residence Characteristics; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
Evaluation of crystal violet decolorization assay for minimal inhibitory concentration detection of primary antituberculosis drugs against Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Biological Assay; Drug Resistance, Multiple, Bacterial; Ethambutol; Gentian Violet; Humans; Indicators and Reagents; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2016 |
Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Ethiopia; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Odds Ratio; Prevalence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
Frequency of adverse events observed with second-line drugs among patients treated for multidrug-resistant tuberculosis.
Topics: Adult; Antitubercular Agents; Cohort Studies; Cycloserine; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Humans; Kanamycin; Male; Ofloxacin; Pyrazinamide; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
[Analysis on drug resistance of Mycobacterium tuberculosis and influencing factors in six provinces of China].
Topics: Antitubercular Agents; China; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Rifampin; Risk Factors; Streptomycin; Surveys and Questionnaires; Tuberculosis, Multidrug-Resistant | 2016 |
Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Ethambutol; Female; Humans; Inappropriate Prescribing; Japan; Kaplan-Meier Estimate; Logistic Models; Lung Diseases; Macrolides; Male; Middle Aged; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Tuberculosis, Multidrug-Resistant | 2016 |
Drug-resistant tuberculosis in Central Mozambique: the role of a rapid genotypic susceptibility testing.
Topics: Adult; Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mozambique; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2016 |
Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.
Topics: Adolescent; Adult; Age Factors; Alcohol Drinking; Amidohydrolases; Antitubercular Agents; Biological Assay; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Gene Expression; Humans; Longitudinal Studies; Male; Middle Aged; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Risk Factors; Sensitivity and Specificity; Sequence Analysis, DNA; Sex Factors; Sputum; Tuberculosis, Multidrug-Resistant | 2016 |
Comprehensive cost of treating one patient with MDR/pre-XDR-TB in Wellington, New Zealand.
Topics: Adult; Amikacin; Aminosalicylic Acid; Anti-Bacterial Agents; Antitubercular Agents; Bronchoscopy; Clofazimine; Depression; Drug Costs; Emigrants and Immigrants; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Health Care Costs; Humans; India; Isoniazid; Linezolid; Male; Mediastinum; Microbial Sensitivity Tests; Moxifloxacin; New Zealand; Pyrazinamide; Radiography, Thoracic; Rifampin; Schizophrenia, Paranoid; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 2016 |
Drug susceptibility profiles of pulmonary Mycobacterium tuberculosis isolates from patients in informal urban settlements in Nairobi, Kenya.
Topics: Adolescent; Adult; Antitubercular Agents; Cities; Cross-Sectional Studies; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Kenya; Male; Middle Aged; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2016 |
Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
Topics: Amidohydrolases; Antitubercular Agents; Bacterial Proteins; Catalase; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Pentosyltransferases; Polymorphism, Restriction Fragment Length; Pyrazinamide; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant | 2016 |
Applicability of the shorter 'Bangladesh regimen' in high multidrug-resistant tuberculosis settings.
Topics: Antitubercular Agents; Clinical Protocols; Diarylquinolines; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Moxifloxacin; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Tuberculosis, Multidrug-Resistant; World Health Organization | 2017 |
Drug-resistant tuberculosis among previously treated patients in Yangon, Myanmar.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Gene Expression; Genome, Bacterial; Humans; Isoniazid; Male; Middle Aged; Mutation; Myanmar; Mycobacterium tuberculosis; Recurrence; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Whole Genome Sequencing | 2016 |
Applicability of the World Health Organization recommended new shorter regimen in a multidrug-resistant tuberculosis high burden country.
Topics: Adult; Antitubercular Agents; Communicable Disease Control; Drug Administration Schedule; Ethambutol; Female; Humans; Infectious Disease Medicine; Male; Mycobacterium tuberculosis; Ofloxacin; Pakistan; Pyrazinamide; Streptomycin; Tuberculosis, Multidrug-Resistant; World Health Organization; Young Adult | 2017 |
Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, Mali.
Topics: Adolescent; Adult; Antitubercular Agents; Cohort Studies; Early Diagnosis; Ethambutol; Female; Humans; Isoniazid; Male; Mali; Microbial Sensitivity Tests; Microscopy; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
TB Alliance regimen development for multidrug-resistant tuberculosis.
Topics: Antitubercular Agents; Clinical Protocols; Diarylquinolines; Dose-Response Relationship, Drug; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Linezolid; Moxifloxacin; Nitroimidazoles; Pyrazinamide; Randomized Controlled Trials as Topic; Research Design; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
Drug resistance profile of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Jos, Nigeria.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Nigeria; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2009 |
Mycobacterium tuberculosis and nontuberculous mycobacterial isolates among patients with recent HIV infection in Mozambique.
Topics: Adult; Antitubercular Agents; CD4 Lymphocyte Count; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mozambique; Mycobacterium avium Complex; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2008 |
Prevalence of tuberculosis drug resistance in 10 provinces of China.
Topics: Antitubercular Agents; China; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Reproducibility of Results; Rifampin; Sputum; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization | 2008 |
[Drug-resistant pulmonary tuberculosis at the penitentiaries].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Prisoners; Rifampin; Russia; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2008 |
[Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
Topics: Adolescent; Age Factors; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2009 |
Radiometric vs. agar proportion methods for assessing ethionamide resistance and its clinical effects in multidrug-resistant tuberculosis.
Topics: Adolescent; Adult; Agar; Antitubercular Agents; Chi-Square Distribution; Child; Ethambutol; Ethionamide; Humans; Isoniazid; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Radiometry; Regression Analysis; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Turkey | 2009 |
Moxifloxacin versus ethambutol in initial tuberculosis treatment.
Topics: Antitubercular Agents; Aza Compounds; Drug Administration Schedule; Ethambutol; Fluoroquinolones; Humans; Medication Adherence; Moxifloxacin; Patient Selection; Practice Guidelines as Topic; Quinolines; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2009 |
Proficiency of drug susceptibility testing for Mycobacterium tuberculosis in Taiwan.
Topics: Antitubercular Agents; Bacteriological Techniques; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Observer Variation; Predictive Value of Tests; Quality Assurance, Health Care; Quality Control; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Streptomycin; Taiwan; Tuberculosis, Multidrug-Resistant | 2009 |
Tuberculosis ethambutol resistance: concordance between phenotypic and genotypic test results.
Topics: Antitubercular Agents; Drug Discovery; Ethambutol; Genotype; Humans; Mutation; Mycobacterium tuberculosis; Phenotype; Tuberculosis; Tuberculosis, Multidrug-Resistant; Uzbekistan | 2009 |
Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
Topics: Antitubercular Agents; Bacterial Proteins; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ethambutol; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Genes, Bacterial; Humans; Ionophores; Isoniazid; Membrane Transport Proteins; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Rifampin; Streptomycin; Stress, Physiological; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2010 |
New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability.
Topics: Antitubercular Agents; Aza Compounds; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Humans; In Vitro Techniques; Isoniazid; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2010 |
Drug-susceptibility patterns of Mycobacterium tuberculosis in Mpumalanga province, South Africa: possible guiding design of retreatment regimen.
Topics: Adolescent; Adult; Age Distribution; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prevalence; Retreatment; Rifampin; Risk Factors; South Africa; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2010 |
Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.
Topics: Antitubercular Agents; Bacterial Proteins; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Genotype; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycobacterium tuberculosis; Point Mutation; Sensitivity and Specificity; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2010 |
Drug resistance pattern in multidrug resistance pulmonary tuberculosis patients.
Topics: Adult; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; Humans; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pakistan; Pyrazinamide; Retrospective Studies; Risk Factors; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2010 |
[A case of multidrug-resistant tuberculosis who acquired additional resistance to ethambutol before the result of the initial drug sensitivity test was reported].
Topics: Antitubercular Agents; Ethambutol; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2010 |
[Epidemiology of the resistance of Mycobacterium tuberculosis to antituberculosis drugs at the main hospital in Dakar, Senegal. A 4-year retrospective study (2000-2003)].
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Hospitals, University; Humans; Immunocompromised Host; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Senegal; Streptomycin; Treatment Failure; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2010 |
Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Comorbidity; Cross-Sectional Studies; Epidemics; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Multivariate Analysis; Prevalence; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2010 |
Susceptibility of clinical Mycobacterium tuberculosis isolates to a potentially less toxic derivate of linezolid, PNU-100480.
Topics: Acetamides; Antitubercular Agents; Ethambutol; Isoniazid; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2011 |
Drug resistance among Mycobacterium tuberculosis isolates from private clinics and a dots center in Delhi, India.
Topics: Adult; Antitubercular Agents; Directly Observed Therapy; Ethambutol; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Young Adult | 2011 |
Rapid detection of ethambutol-resistant Mycobacterium tuberculosis directly from sputum samples by radioisotope (32P)-based PCR dot blot hybridization and sequencing methods.
Topics: Antitubercular Agents; Base Sequence; Codon; Drug Resistance, Multiple, Bacterial; Ethambutol; Feasibility Studies; Genotype; Humans; Mutation; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Pentosyltransferases; Phosphorus Radioisotopes; Polymerase Chain Reaction; Sputum; Time Factors; Tuberculosis, Multidrug-Resistant | 2011 |
[Susceptibility of M. tuberculosis to antituberculosis drugs as determined by two methods, in Sucre state, Venezuela].
Topics: Antitubercular Agents; Bacterial Proteins; Base Sequence; DNA-Directed RNA Polymerases; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Sequence Data; Morbidity; Mutation, Missense; Mycobacterium tuberculosis; Nitrate Reductase; Point Mutation; Prevalence; Rifampin; Sequence Alignment; Sequence Homology, Nucleic Acid; Sputum; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Venezuela | 2010 |
Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; DNA, Bacterial; Ethambutol; Genotype; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Mycobacterium tuberculosis; Sensitivity and Specificity; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2011 |
Resistance to first-line tuberculosis drugs in three cities of Nigeria.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Cities; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Nigeria; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Urban Health; Young Adult | 2011 |
Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Topics: Adult; Antitubercular Agents; Cohort Studies; DNA Mutational Analysis; Ethambutol; Humans; Isoniazid; Jordan; Microbial Sensitivity Tests; Molecular Typing; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2011 |
Isoniazid-resistant intracranial tuberculoma treated with a combination of moxifloxacin and first-line anti-tuberculosis medication.
Topics: Antitubercular Agents; Aza Compounds; Biopsy; Brain; Cerebrospinal Fluid; Drug Resistance, Bacterial; Ethambutol; Female; Fluoroquinolones; Histocytochemistry; Humans; Isoniazid; Magnetic Resonance Imaging; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculoma, Intracranial; Tuberculosis, Multidrug-Resistant; Young Adult | 2011 |
Acute liver failure in a pediatric patient with disseminated tuberculosis.
Topics: Antifungal Agents; Antitubercular Agents; Child; Coccidioidomycosis; Drug Therapy, Combination; Ethambutol; Fluconazole; Humans; Isoniazid; Liver Failure, Acute; Male; Pyrazinamide; Recovery of Function; Rifampin; Tuberculosis, Multidrug-Resistant | 2011 |
Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China.
Topics: Antitubercular Agents; Base Sequence; China; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Genetic Markers; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pentosyltransferases; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2011 |
High prevalence of multidrug-resistant tuberculosis in Zunyi, Guizhou Province of China.
Topics: Antitubercular Agents; China; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2011 |
Fluoroquinolone-resistant tuberculosis at a medical centre in Taiwan, 2005-10.
Topics: Adult; Aged; Aged, 80 and over; Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Female; Fluoroquinolones; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifabutin; Rifampin; Streptomycin; Taiwan; Tuberculosis, Multidrug-Resistant | 2011 |
Correlation of the phenotypic ethambutol susceptibility of Mycobacterium tuberculosis with embB gene mutations in Korea.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Gene Expression Regulation, Bacterial; Humans; Mutation; Mycobacterium tuberculosis; Pentosyltransferases; Republic of Korea; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2012 |
Therapeutic drug monitoring in the treatment of tuberculosis patients.
Topics: Adult; Aged; Alcoholism; Antibiotics, Antitubercular; Antitubercular Agents; Chromatography, High Pressure Liquid; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Monitoring; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Precision Medicine; Pyrazinamide; Recurrence; Rifampin; Schizophrenia; Sputum; Treatment Failure; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2012 |
Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.
Topics: Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Ethambutol; Genotype; Humans; Kanamycin; Kanamycin Resistance; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pentosyltransferases; Phenotype; Polymerase Chain Reaction; Predictive Value of Tests; RNA, Bacterial; RNA, Ribosomal, 16S; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2012 |
GenoType MTBDRsl performance on clinical samples with diverse genetic background.
Topics: Antitubercular Agents; Base Sequence; Ethambutol; Fluoroquinolones; Genetic Variation; Genotyping Techniques; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium tuberculosis; Predictive Value of Tests; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2012 |
Strategies for treating latent multiple-drug resistant tuberculosis: a decision analysis.
Topics: Animals; Antitubercular Agents; Aza Compounds; Cost-Benefit Analysis; Decision Support Techniques; Drug Therapy; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Markov Chains; Mice; Models, Theoretical; Moxifloxacin; Outcome Assessment, Health Care; Quality-Adjusted Life Years; Quinolines; Rifampin; Tuberculosis, Multidrug-Resistant | 2012 |
A simple and economical in-house phage technique for the rapid detection of rifampin, isoniazid, ethambutol, streptomycin, and ciprofloxacin drug resistance in Mycobacterium tuberculosis, directly on decontaminated sputum samples.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Ciprofloxacin; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Microbial Viability; Middle Aged; Mycobacteriophages; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Virus Replication; Young Adult | 2012 |
Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Genotype; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2012 |
Relatively low primary drug resistant tuberculosis in southwestern Ethiopia.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethiopia; Female; HIV Infections; Humans; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Odds Ratio; Prevalence; Rifampin; Risk Assessment; Risk Factors; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2012 |
The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.
Topics: Adolescent; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Child, Preschool; Coinfection; Epidemics; Ethambutol; Female; HIV Infections; Humans; Infant; Infant, Newborn; Isoniazid; Male; Mycobacterium tuberculosis; Prevalence; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant | 2012 |
Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient.
Topics: Adult; Antitubercular Agents; Clarithromycin; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; HIV Seronegativity; Humans; Isoniazid; Kanamycin; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2012 |
Susceptibility testing to second-line drugs and ethambutol by GenoType MTBDRsl and Bactec MGIT 960 comparing with agar proportion method.
Topics: Agar; Antitubercular Agents; DNA Mutational Analysis; DNA, Bacterial; Ethambutol; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Microbial Sensitivity Tests; Predictive Value of Tests; Reagent Strips; RNA, Bacterial; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2012 |
In-house, simple & economical phage technique for rapid detection of rifampicin, isoniazid, ethambutol, streptomycin & ciprofloxacin drug resistance using Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Bacteriophages; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis, Multidrug-Resistant | 2012 |
Drug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa.
Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Cohort Studies; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Kanamycin; Male; Prevalence; Rifampin; South Africa; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant | 2012 |
Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments.
Topics: Aminoglycosides; Antitubercular Agents; Base Sequence; Communicable Disease Control; Drug Resistance, Bacterial; Ethambutol; Fluoroquinolones; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Multiplex Polymerase Chain Reaction; Mycobacterium tuberculosis; Sensitivity and Specificity; Sequence Analysis, DNA; Sputum; Tuberculosis, Multidrug-Resistant | 2012 |
Evaluation of tuberculosis underreporting in Greece through comparison with anti-tuberculosis drug consumption.
Topics: Antitubercular Agents; Epidemiological Monitoring; Ethambutol; Greece; Humans; Isoniazid; Latent Tuberculosis; Prescription Drugs; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2012 |
[Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Poland; Prevalence; Prospective Studies; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Russia; Streptomycin; Time Factors; Treatment Failure; Tuberculosis, Multidrug-Resistant | 2002 |
Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Directly Observed Therapy; Ethambutol; Follow-Up Studies; Humans; India; Isoniazid; Retrospective Studies; Rifampin; Streptomycin; Time Factors; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
Drug-resistant Mycobacterium tuberculosis among new tuberculosis patients, Yangon, Myanmar.
Topics: AIDS-Related Opportunistic Infections; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Myanmar; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000.
Topics: Antitubercular Agents; Cycloserine; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Taiwan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
[Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Directly Observed Therapy; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Madagascar; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Mycobacterium tuberculosis; National Health Programs; Population Surveillance; Prospective Studies; Recurrence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Urban Health | 2002 |
Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Typing Techniques; Ethambutol; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Prisoners; Russia; Species Specificity; Streptomycin; Tuberculosis, Multidrug-Resistant | 2003 |
RE-TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS AT BATTEY STATE HOSPITAL.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethambutol; Ethionamide; Geriatrics; Hospitals, State; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Viomycin | 1964 |
Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Interviews as Topic; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Peru; Prevalence; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 2003 |
Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Polymerase Chain Reaction; Reproducibility of Results; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2004 |
Direct rapid diagnosis of rifampicin-resistant M. tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB).
Topics: Antibiotics, Antitubercular; Ascitic Fluid; Bronchoalveolar Lavage Fluid; Cerebrospinal Fluid; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Genes, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Pleural Effusion; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Urine | 2004 |
Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
Topics: Antitubercular Agents; Colony Count, Microbial; Culture Media; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sampling Studies; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2004 |
[Miss-management in treatment failure of pulmonary tuberculosis].
Topics: Adult; Aged; Antitubercular Agents; Chronic Disease; Directly Observed Therapy; Drug Therapy, Combination; Empyema, Tuberculous; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Patient Compliance; Quality of Health Care; Retrospective Studies; Rifampin; Risk Factors; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
Treatment outcome of multidrug-resistant tuberculosis among Vietnamese immigrants.
Topics: Capreomycin; Cycloserine; Drug Therapy, Combination; Emigration and Immigration; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Ofloxacin; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Vietnam | 2005 |
High prevalence of drug-resistant tuberculosis, Republic of Lithuania, 2002.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Ethambutol; Female; Humans; Isoniazid; Lithuania; Male; Middle Aged; Mycobacterium tuberculosis; Prevalence; Random Allocation; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2005 |
Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Codon; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2005 |
Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Oligonucleotides; Pentosyltransferases; Phenotype; Polymerase Chain Reaction; Radiometry; Tuberculosis, Multidrug-Resistant | 2005 |
Multidrug-resistant tuberculous spondylodiscitis: need for aggressive management and drug susceptibility testing of Mycobacterium tuberculosis isolates.
Topics: Anti-Bacterial Agents; Biopsy, Fine-Needle; Bone Transplantation; Cycloserine; Discitis; Drug Therapy, Combination; Ethambutol; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Streptomycin; Thoracic Vertebrae; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Osteoarticular; Vitamin B 6; Vitamin B Complex | 2006 |
High hepatotoxicity of pyrazinamide and ethambutol for treatment of latent tuberculosis.
Topics: Adult; Antitubercular Agents; Carrier State; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethambutol; Female; Follow-Up Studies; Humans; Liver Function Tests; Male; Middle Aged; Pyrazinamide; Tuberculosis, Multidrug-Resistant | 2005 |
Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2005 |
Mycobacterium tuberculosis in a Saudi Arabian hospital.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Saudi Arabia; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2006 |
Blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line drugs.
Topics: Agar; Antitubercular Agents; Blood; Culture Media; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2006 |
Enhanced susceptibility of multidrug resistant strains of Mycobacterium tuberculosis to granulysin peptides correlates with a reduced fitness phenotype.
Topics: Antigens, Differentiation, T-Lymphocyte; Antitubercular Agents; Bacterial Proteins; Cells, Cultured; Colony Count, Microbial; Cytoplasm; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ethambutol; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peptides; Streptolysins; Tuberculosis, Multidrug-Resistant | 2006 |
[Treatment outcome of patients with multidrug-resistant pulmonary tuberculosis during pregnancy].
Topics: Adult; Aminosalicylic Acid; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Cycloserine; Drug Resistance, Multiple; Ethambutol; Female; Humans; Mutation; Mycobacterium tuberculosis; Parturition; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pyrazinamide; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2006 |
Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.
Topics: Alleles; Antibiotics, Antitubercular; Antitubercular Agents; Biological Evolution; DNA Mutational Analysis; DNA, Bacterial; DNA, Intergenic; Ethambutol; Gene Deletion; Genes, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Open Reading Frames; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2006 |
Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
Topics: Adolescent; Adult; Age Factors; Aged; Analysis of Variance; Anti-Bacterial Agents; Antibiotics, Antitubercular; British Columbia; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Emigration and Immigration; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Odds Ratio; Pyrazinamide; Rifampin; Risk Factors; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2006 |
Multidrug-resistant tuberculosis of the ankle: case report.
Topics: Antitubercular Agents; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Hospitalization; Humans; Magnetic Resonance Imaging; Pyrazinamide; Talus; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Osteoarticular | 2006 |
Comparison between molecular epidemiology, geographical regions and drug resistance in Mycobacterium tuberculosis strains isolated from Iranian and Afghan patients.
Topics: Adult; Afghanistan; Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Resistance, Multiple, Bacterial; Ethambutol; Genotype; Humans; Iran; Isoniazid; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Mycobacterium tuberculosis; Prevalence; Rifampin; Risk Factors; Streptomycin; Tuberculosis, Multidrug-Resistant | 2006 |
National anti-tuberculosis drug resistance survey, 2002, in Myanmar.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Cross-Sectional Studies; Ethambutol; Female; Health Surveys; Humans; Isoniazid; Male; Middle Aged; Myanmar; Rifampin; Risk Factors; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2006 |
Primary and acquired drug resistance in childhood tuberculosis.
Topics: Adolescent; Afghanistan; Antitubercular Agents; Child; Child Welfare; Ethambutol; Female; Gastric Juice; Humans; Iran; Isoniazid; Male; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Refugees; Retrospective Studies; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2006 |
Trend of anti-tuberculosis drug resistance in Korea, 1994-2004.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Ethambutol; Humans; Isoniazid; Korea; Middle Aged; Prevalence; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
[Tuberculosis caused by XDR resistant Mycobacterium tuberculosis in Poland. Microbiological and molecular analysis].
Topics: Antitubercular Agents; Capreomycin; DNA Fingerprinting; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Epidemiology; Mycobacterium tuberculosis; Poland; Population Surveillance; Prevalence; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2007 |
Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antitubercular Agents; Comorbidity; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Prevalence; Retrospective Studies; Rifampin; Streptomycin; Thailand; Tuberculosis, Multidrug-Resistant | 2007 |
[Primary resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Kinshasa, (DRC)].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Cross-Sectional Studies; Democratic Republic of the Congo; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Prevalence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
Nationwide survey on the prevalence of anti-tuberculosis drug resistance in the Republic of Yemen, 2004.
Topics: Adult; Antitubercular Agents; Chi-Square Distribution; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Prevalence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Yemen | 2007 |
Drug susceptibility profiling of tuberculous meningitis.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Infant; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant | 2008 |
Treatment of isoniazid-resistant pulmonary tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Medical Audit; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2008 |
Outcome of multi-drug resistant tuberculosis cases treated by individualized regimens at a tertiary level clinic.
Topics: Adolescent; Adult; Aminoglycosides; Aminosalicylic Acid; Antitubercular Agents; Child; Cycloserine; Ethambutol; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pyrazinamide; Radiography; Severity of Illness Index; Thioamides; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2008 |
Failure of drug penetration and acquisition of drug resistance in chronic tuberculous empyema.
Topics: Aged; Antitubercular Agents; Chronic Disease; Empyema, Tuberculous; Ethambutol; Humans; Male; Ofloxacin; Pleural Effusion; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 1995 |
Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis.
Topics: Acetaminophen; Adult; Capreomycin; Ciprofloxacin; Drug Combinations; Drug Overdose; Ethambutol; Female; Humans; Isoniazid; Liver; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1994 |
Drugs for tuberculosis.
Topics: Adult; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1995 |
Drug resistance of Mycobacterium tuberculosis strains isolated from HIV-infected Italian patients: preliminary report from a multicentric study. The Italian Tuberculosis Drug Resistance Study Group.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; HIV Infections; Humans; Isoniazid; Italy; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 1995 |
[Therapy of tuberculosis in the adult].
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1995 |
Transient exacerbation of tuberculous lymphadenitis during chemotherapy in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Leukocyte Count; Male; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 1994 |
High initial and acquired drug resistance in pulmonary tuberculosis in Turkey.
Topics: Adolescent; Adult; Age Distribution; Aged; Antitubercular Agents; Child; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Prevalence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Turkey | 1994 |
Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Clinical Protocols; Drug Monitoring; Ethambutol; Humans; Infant; Isoniazid; Patient Compliance; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1994 |
Superinfection with rifampin-isoniazid-streptomycin-ethambutol (RISE)-resistant tuberculosis in three patients with AIDS: confirmation by polymerase chain reaction fingerprinting.
Topics: Adult; AIDS-Related Opportunistic Infections; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Streptomycin; Superinfection; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1994 |
[Incidence of resistance of tuberculosis bacteria in Switzerland].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Drug Resistance, Microbial; Ethambutol; Humans; Incidence; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Rifampin; Switzerland; Tuberculosis, Multidrug-Resistant | 1993 |
The third epidemic--multidrug-resistant tuberculosis.
Topics: Adult; Age Factors; Comorbidity; Disease Outbreaks; Drug Resistance, Microbial; Ethambutol; Female; HIV Seropositivity; Humans; Ill-Housed Persons; Isoniazid; Male; Minority Groups; Mycobacterium tuberculosis; New York City; Rifampin; Sex Factors; Streptomycin; Substance Abuse, Intravenous; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Unemployment | 1994 |
Prevalence of initial drug resistance in tuberculosis patients attending a chest hospital.
Topics: Adolescent; Adult; Drug Resistance; Ethambutol; Female; Hospitals, Special; Humans; India; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1993 |
Clinical manifestation and outcome of tuberculosis in children with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Capreomycin; Child; Child, Preschool; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Microbial Sensitivity Tests; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Hospital transmission of multidrug-resistant Mycobacterium tuberculosis in Rosario, Argentina.
Topics: Acquired Immunodeficiency Syndrome; Adult; Argentina; Chronic Disease; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Blotting, Southern; Cause of Death; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Ethambutol; Female; HIV Infections; Humans; Infant; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; New York City; Polymorphism, Restriction Fragment Length; Proportional Hazards Models; Rifampin; Sputum; Streptomycin; Survival Analysis; Tuberculosis, Multidrug-Resistant | 1996 |
Trismus and preauricular swelling in a 20-year-old black woman.
Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Capreomycin; Diagnosis, Differential; Edema; Ethambutol; Female; Haiti; Humans; Ofloxacin; Temporomandibular Joint Disorders; Trismus; Tuberculosis, Multidrug-Resistant; Tuberculosis, Oral; Tuberculosis, Osteoarticular | 1996 |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Nontuberculous Mycobacteria; Practice Guidelines as Topic; Pyrazinamide; Pyridoxine; Radiography; Rifabutin; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
Topics: Antitubercular Agents; Clinical Laboratory Information Systems; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Population Surveillance; Quality Assurance, Health Care; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; World Health Organization | 1997 |
Primary resistance to anti-tuberculosis drugs in Addis Ababa, Ethiopia.
Topics: Antitubercular Agents; Cross-Sectional Studies; Developing Countries; Drug Resistance, Multiple; Drug Therapy, Combination; Ethambutol; Ethiopia; Humans; Isoniazid; Microbial Sensitivity Tests; Multicenter Studies as Topic; Mycobacterium tuberculosis; Prevalence; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Multidrug-Resistant | 1997 |
[Surgical treatment of patients with multi-resistant pulmonary tuberculosis--case reports].
Topics: Adult; Antitubercular Agents; Bronchial Fistula; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Humans; Isoniazid; Male; Middle Aged; Pleural Diseases; Pneumonectomy; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
[Reasons for chronic expectoration--case reports].
Topics: Adult; Aged; Antitubercular Agents; Capreomycin; Cycloserine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Rifampin; Secondary Prevention; Sputum; Streptomycin; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
Drug-resistant tuberculosis in Singapore, 1995 to 1996.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; AIDS-Related Opportunistic Infections; Antitubercular Agents; Case-Control Studies; Ethambutol; Female; Humans; Incidence; Isoniazid; Male; Middle Aged; Recurrence; Rifampin; Singapore; Streptomycin; Tuberculosis, Multidrug-Resistant | 1997 |
How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Ethambutol; HIV Seropositivity; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Patient Compliance; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995.
Topics: Adult; Age Distribution; Aged; Antitubercular Agents; Confidence Intervals; Ethambutol; Female; Humans; Incidence; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; New Jersey; Odds Ratio; Population Surveillance; Pyrazinamide; Rifampin; Risk Factors; Sex Distribution; Streptomycin; Tuberculosis, Multidrug-Resistant | 1998 |
Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.
Topics: Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Microbial; Ethambutol; Global Health; Humans; Isoniazid; Mycobacterium tuberculosis; Population Surveillance; Prevalence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 1998 |
Drug-resistant tuberculosis of the brain in a two-year-old child.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Brain Diseases; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Hip Joint; Humans; Magnetic Resonance Imaging; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary | 1998 |
Synergistic activities of antituberculous drugs with cerulenin and trans-cinnamic acid against Mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Cerulenin; Cinnamates; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 1998 |
[Resistance and multiresistance to antitubercular drugs in Argentina and in other Latin American countries].
Topics: Acquired Immunodeficiency Syndrome; Antitubercular Agents; Argentina; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Latin America; Mycobacterium tuberculosis; Pyrazinamide; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
Drug-resistant tuberculosis in Budapest.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Hungary; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
[Resistance of mycobacterial tuberculosis complex to the main antibacillary agent in Yaounde, Cameroon].
Topics: Adolescent; Adult; Antitubercular Agents; Cameroon; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Thioacetazone; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
Susceptibility of multidrug-resistant strains of Mycobacterium tuberculosis to amoxycillin in combination with clavulanic acid and ethambutol.
Topics: Amoxicillin; Antitubercular Agents; beta-Lactamases; Clavulanic Acid; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 1998 |
Drug-resistant tuberculosis in the Philippines.
Topics: Antitubercular Agents; Drug Resistance, Multiple; Ethambutol; Female; Humans; Incidence; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Philippines; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 1999 |
First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Azerbaijan; Dietary Supplements; Ethambutol; Humans; Isoniazid; Logistic Models; Male; Mycobacterium tuberculosis; Patient Compliance; Pilot Projects; Prisoners; Prisons; Rifampin; Sputum; Streptomycin; Survival Rate; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; World Health Organization | 1999 |
Is the treatment of WHO category I tuberculosis with 2HRZE/6HE a defensible practice?
Topics: Antitubercular Agents; Developing Countries; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; World Health Organization | 1999 |
[Breast abscess and pregnancy toxemia revealing multidrug resistant tuberculosis].
Topics: Abscess; Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Breast Diseases; Bronchoscopy; Cesarean Section; Ciprofloxacin; Drug Therapy, Combination; Eclampsia; Ethambutol; Female; Follow-Up Studies; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Radiography, Thoracic; Time Factors; Tomography, X-Ray Computed; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1999 |
Anti-tuberculosis drug resistance in Portugal.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Population Surveillance; Portugal; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2000 |
Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.
Topics: Antitubercular Agents; Dominican Republic; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethambutol; Global Health; Hong Kong; Humans; Isoniazid; Italy; Korea; Peru; Program Evaluation; Retrospective Studies; Rifampin; Risk; Russia; Streptomycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; World Health Organization | 2000 |
[Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Cote d'Ivoire; Ethambutol; Female; Humans; Isoniazid; Male; Medical History Taking; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2000 |
Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998.
Topics: Adult; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; HIV Seropositivity; Humans; Isoniazid; Malawi; Male; Microbial Sensitivity Tests; Middle Aged; Recurrence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2000 |
[Primary and acquired drug resistance of tuberculosis bacilli in Poland].
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Child; Ethambutol; Female; Health Surveys; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Poland; Rifampin; Sex Distribution; Species Specificity; Tuberculosis, Multidrug-Resistant | 1999 |
[Evolution of drug-resistant Mycobacterium tuberculosis in the province of Castellón. 1992-1998].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Multiple; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Risk Factors; Spain; Streptomycin; Tuberculosis, Multidrug-Resistant | 2000 |
Tuberculosis treatment: dangerous regimens?
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; World Health Organization | 2001 |
Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Pyrazinamide; Rifampin; Saudi Arabia; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
Topics: Adolescent; Adult; Age Distribution; Aged; Antitubercular Agents; Directly Observed Therapy; Ethambutol; Female; Hong Kong; Humans; Isoniazid; Longitudinal Studies; Male; Middle Aged; Mycobacterium tuberculosis; Population Surveillance; Prevalence; Retrospective Studies; Rifampin; Sex Distribution; Streptomycin; Time Factors; Tuberculosis, Multidrug-Resistant | 2001 |
Determinants of drug-resistant tuberculosis: analysis of 11 countries.
Topics: Adolescent; Adult; Africa; Age Factors; Americas; Antibiotics, Antitubercular; Asia; Child; Child Welfare; Child, Preschool; Drug Resistance, Multiple; Ethambutol; Europe; Female; HIV; HIV Infections; Humans; Infant; Infant Welfare; Infant, Newborn; Male; Middle Aged; Multivariate Analysis; Population Surveillance; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant | 2001 |
Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Clinical Protocols; Drug Combinations; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Mass Screening; Middle Aged; Mycobacterium tuberculosis; Pilot Projects; Population Surveillance; Qatar; Retrospective Studies; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
Sample survey of drug-resistant tuberculosis in Henan, China, 1996.
Topics: Adult; Aged; China; Data Collection; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization | 2002 |
Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
Topics: Adult; Antibiotics, Antitubercular; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Prevalence; Retrospective Studies; Rifampin; Saudi Arabia; Sputum; Streptomycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
An unusual epidemic of isoniazid resistant tuberculosis in a western Alaska Eskimo village-portents for the future?
Topics: Adolescent; Adult; Alaska; Child; Child, Preschool; Disease Outbreaks; Ethambutol; Female; Humans; Infant; Inuit; Isoniazid; Male; Tuberculosis, Multidrug-Resistant | 1991 |